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Abstract 
 
 Dopamine is a modulatory neurotransmitter that signals the saliency of the 
environmental input and is involved in the learned formation of responses. Dopamine 
neurons exist in twelve distinct nuclei throughout the brain, including the substantia nigra 
pars compacta and ventral tegmental area. The dopamine neurons in these two nuclei 
send projections to the extended striatum and frontal cortex. These dopamine neurons fire 
intrinsically at about 5 Hz, creating a baseline low nanomolar extracellular dopamine 
concentration in the striatum that can be measured using microdialysis. This suggests that 
baseline dopamine is essential for proper brain function. Dysfunction in the dopamine 
system leads to diseases such as Parkinson’s disease, addiction, schizophrenia and others. 
Currently, most of what we know about dopamine neurotransmission has been inferred 
from studies of other neurotransmitter systems. Because dopamine is a modulatory 
neurotransmitter, it is difficult to study dopamine signaling directly. Greater knowledge 
of dopamine release, re-uptake and receptor binding is vital in understanding the 
dopamine system as a whole and would provide valuable data to better treat the disease 
states associated with dopamine signaling. Herein, I will present research aimed at 
dissecting the parameters necessary to build a complete computer model of a dopamine 
varicosity to be used to better understand dopamine signaling.  
 Chapter 1 introduces the extended striatum, the various neurons and inputs 
present in the striatum, and the dopamine system in this brain region. This chapter will 
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focus on the characteristics of each and how each part of the striatum contributes to its 
overall function. Next, the chapter will discuss in detail the characteristics of the 
dopamine system as a whole including dopamine transmission, receptors and transporters 
involved in signaling and the modulatory function of the neurotransmitter. 
 Chapter 2 presents the findings that dopamine release probability in the striatum is 
low. A computer simulation of a single dopamine release site was used to determine that 
less than one vesicle needs to be released per firing event to maintain the reported 
baseline extracellular concentration. The simulation model was also used to determine the 
amount of dopamine released to match published data of extracellular dopamine 
following electrical stimulation in vitro. The model suggests that the dopamine release 
induced by a single electrical stimulation may be as large as two vesicles. Our findings 
argue that dopamine release at any one particular varicosity is very low. 
 Chapter 3 presents the findings of a literature review to determine the quantitative 
details of all aspects in the striatal complex. These details provided evidence that, while 
the striatum is typically thought of as a dopaminergic area, quantitatively dopamine is a 
minor system compared to others present in the striatum. While dopamine’s number of 
varicosities and receptors is lower than other systems, we also determined on which 
elements the receptors are located. We found that dopamine receptors have a diffuse 
presence. This suggests that dopamine has the capability to modulate the overall output of 
the striatum. 
 Chapter 4 presents the findings of a computer simulation of dopamine receptor 
binding in the vicinity of a single release site under multiple conditions. Baseline, tonic 
dopamine release results in about half of the dopamine D2 receptors being occupied 
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while no D1 receptors are occupied. A phasic burst of dopamine has little effect on 
receptor binding overall. A 30% increase in release probability is necessary to occupy a 
majority of D1 receptors. In this chapter we also explored the effects of a more complex 
simulation space and found that as the extracellular dopamine concentration increases, 
the location of D1 receptors becomes an important factor in receptor binding.   
 Chapter 5 presents the findings of a computer simulation of dopamine receptor 
binding in the vicinity of a single release site in the presence of cocaine or amphetamine. 
The highest dose of cocaine tested (25 mg/kg) only increased D1 receptor binding 4% 
and almost saturated the D2 receptors in the model. Modeling of the presence of 2 mg/kg 
amphetamine led to a 13% increase in D1 receptor binding and fully saturated D2 
receptors. Our findings argue that the effects of cocaine are more likely due to D2 
receptor activation and some of amphetamine’s effects may be due to D1 receptor 
activation.   
 Finally, chapter 6 summarizes the findings and significance of this dissertation 
research as well as provides future perspectives. In summary, this dissertation has: (I) 
summarized the function and overall organization of the striatal complex and dopamine 
system, (II) determined that dopamine release probability at any one particular release 
site is low, (III) determined the quantitative details of the elements within the striatum, 
(IV) studied dopamine D1 and D2 receptor binding under tonic and phasic firing 
conditions and (V) characterized receptor binding in the presence of the psychostimulants 
cocaine and amphetamine.  
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Chapter 1: Introduction 
 
1.1. Overview 
 
The extended striatum, consisting of regions called dorsal striatum, nucleus 
accumbens core, nucleus accumbens shell, and possibly olfactory tubercle, plays a major 
role in learning, motivation, and development of habits. Dopamine signaling in the 
striatum and nucleus accumbens communicates novelty and saliency of the current 
environmental input and is involved in the learned formation of appropriate responses. 
Dopamine neurons from the ventral tegmental area (VTA) innervate the nucleus 
accumbens (ventral striatum), while dopamine neurons from the substantia nigra pars 
compacta (SNc) innervate the dorsal striatum.  The number of dopaminergic cell bodies 
in VTA and SNC is small, about 20,000-30,000 in mice and 40,000-45,000 in rats 
(Björklund and Dunnett 2007); however, the axonal projections in the expanded striatum 
ramify extensively, forming dense, intricate axonal arborizations. The axonal tree from 
one neuron can influence up to 5.7% of striatal volume. Dopaminergic axons have 
varicosities (dopamine release sites) distributed along their axons within the expanded 
striatum, making an estimated hundred thousand varicosities per neuron (Matsuda et al. 
2009). Therefore, each dopaminergic neuron has the potential to exert a large influence in  
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the striatum (Threlfell and Cragg 2011). Most (more than 75%) of striatal dopaminergic 
varicosities are not associated with synaptic specialization (Descarries et al. 1996). This 
ultrastructural observation coupled with amperometric experiments (Garris and 
Wightman 1994) suggest that dopamine signaling occurs through volume transmission. 
Thus, the neurotransmitter molecules can diffuse and affect receptors within a few 
micrometers of the release site. Dopamine is retrieved from the extracellular signaling 
compartment via the dopamine transporter (DAT) (Gether et al. 2006). Dopaminergic 
neurons fire intrinsically at about 1-5 Hz (Bunney, Aghajanian, and Roth 1973; Koeltzow 
et al. 1998), suggesting that a baseline dopaminergic tone is important to striatal function.  
While we know details about the dopaminergic system as a whole, the neurobiology of 
dopamine release and signaling at the level of the varicosity is still unknown. What 
dopamine release looks like and how its immediate neighborhood is constructed would 
have a large impact on the dopamine signal interpretation and ultimate output of the 
striatum. Using computer models, we are able to construct a plausible model of the 
dopamine varicosity to better understand vesicular release of dopamine and how different 
signaling patterns could interact with the immediate neighborhood.  
 
1.2. Extended Striatum 
 
 The extended striatum is the primary input for the basal ganglia system and is 
involved in the planning and modulation of movement as well as being involved in many 
processes involving executive function. The striatum is composed mainly of medium 
spiny neurons (MSNs), which are GABAergic in nature.  These neurons are the only 
3 
output neuron and account for about 95% of the neurons in the striatum (Dubé, Smith, 
and Bolam 1988).  The other 5% of neurons are interneurons. These include at least three 
different types of GABAergic interneurons as well as a subset of cholinergic 
interneurons. For the purposes of this dissertation, I will focus on two subsections of the 
striatum: the dorsal striatum and the nucleus accumbens.  The dorsal striatum is mainly 
associated with motor control while the nucleus accumbens is associated with reward.  
 The dorsal and ventral striatum (nucleus accumbens shell and core) are extremely 
similar in cellular composition and there are no well-defined borders between the regions.  
They are distinguished by their difference in function and the inputs they receive from 
other brain regions. The dorsal striatum, known as the caudate-putamen in humans, is 
mainly implicated in procedural and stimulus-response learning (Voorn et al. 2004).  This 
area of the brain is also required for the execution of planned motor behavior and is 
implicated in the pathophysiology of Parkinson’s disease and Huntington’s disease 
(Graybiel et al. 1994). 
The nucleus accumbens is thought to play a role in reward and pleasure.  This 
area of the brain receives dopaminergic inputs from the ventral tegmental area, forming 
one component of the reward pathway.  The nucleus accumbens is made up of two 
distinct regions, the core and the shell.  The nucleus accumbens core has been shown to 
play a role in drug reinforcement (Crespo et al. 2006) and drug-seeking behavior (Ito, 
Robbins, and Everitt 2004).  The shell is more sensitive to addicting drugs, though. Both 
regions play a role in learned behavior, but the core seems to respond to conditioned 
reinforcers while the shell seems to enhance certain behavioral responses that are 
coordinated through the core (Voorn et al. 2004). 
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1.2.1. Medium Spiny Neurons 
 
 The main output neuron of the striatum, the medium spiny neuron, sends 
projections along two distinct pathways.  One projection, known as the direct pathway, 
sends fibers to the globus pallidus interna/substantia nigra pars reticulata and expresses 
dopamine D1 receptors.  The indirect pathway sends projections to the globus pallidus 
externa and expresses dopamine D2 receptors.  There is only a 5-15% overlap of 
expression of D1/D2 receptors in MSNs, thus allowing for a distinct segregation of the 
two pathways (Cerovic et al. 2013).   
More than 90% of striatal neurons are known as the medium spiny neuron (MSN).  
They have been given this name due to the appearance of dense spines on their dendritic 
processes. These neurons have an inhibitory function. Thus, the output from the striatal 
complex cannot initiate any behavioral activity. Inhibitory neurons can only modulate 
activities that are driven either by intrinsic pattern generators or via inputs from other 
brain regions. The GABAergic output neurons in the striatal complex do not have an 
intrinsic activity. In the absence of a driving input, they are quiescent. Driving sources 
are glutamatergic inputs from cortex, thalamus, hippocampus, and amygdala. The cortical 
inputs form a topological map from the entire cortex (McGeorge and Faull 1989). This 
suggests that the striatal complex is modulating a wide variety of processes originating in 
the cortex. These would include executive decision-making from the prefrontal cortex, 
motor information from the motor areas, and sensory information from visual and 
auditory cortex areas. The GABAergic output neurons also show substantial collateral 
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axon innervation of neighboring output neurons, suggesting that activity from multiple 
areas of the cortex is integrated in the striatum. 
 
1.2.2. Striatal Interneurons 
 
 The other 5-10% of cells found within the striatum are interneurons. They consist 
of four types of GABA interneurons as well as a subset of cholinergic interneurons.  
 Cholinergic interneurons appear to have a very important role in the striatum.  
These neurons account for somewhere around 1-2% of total neurons in this brain region. 
Axons of cholinergic interneurons in the striatum branch profusely (Contant et al. 1996).  
These neurons are tonically active, providing a constant basal level of acetylcholine in the 
extracellular environment (Bennett and Wilson 1999). As the only other cholinergic 
innervation into the striatum is a very small tract from the pedunculopontine nucleus, the 
vast majority of cholinergic synapses arise from the interneurons. Multiple elements in 
the striatum express muscarinic and nicotinic cholinergic receptors allowing for 
cholinergic modulation of the striatal output.  Every dopamine nerve terminal has a 
nicotinic acetylcholine receptor, which could potentially allow for cholinergic modulation 
of dopamine signaling within the striatum as well.   
The remaining interneurons are GABAergic in nature and are divided into four 
subclasses based on their electrophysiological properties. There are the fast spiking 
GABAergic interneurons, the low threshold spiking interneurons, the calretinin positive 
GABAergic interneurons (Tepper and Bolam 2004) as well as tyrosine hydroxylase 
positive GABAergic interneurons (Ibáñez-Sandoval et al. 2010). The fast spiking 
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neurons, which are also characterized by their expression of parvalbumin, are thought to 
make up about 0.7% of the total neurons in the rat striatum (Luk and Sadikot 2001) and 
are electrotonically coupled via gap junctions (Kita, Kosaka, and Heizmann 1990). The 
fast spiking interneurons receive a glutamatergic input from the cortex as well as 
GABAergic input from MSN axon collaterals and a cholinergic input (Tepper and Bolam 
2004). The low threshold spiking interneurons express neuropeptide Y, somatostatin and 
nitric oxide synthase (Smith and Parent 1986). These neurons account for about 0.8% of 
neurons in the rodent striatum (Rymar et al. 2004) and have the least dense axonal 
arborization (Kawaguchi 1993). The calretinin neurons account for about 0.8% of 
neurons in rodent striatum (Rymar et al. 2004) and are relatively sparse in the caudal 
areas of the striatum (Bennett and Bolam 1993). There are currently no 
electrophysiological data for these cells and their profile is not known. Finally, the 
tyrosine hydroxylase GABAergic interneurons are further divided into four subclasses 
based on their electrophysiological profiles. They were first described in 1987 in the 
primate (Dubach et al. 1987) and since then have been described in other species such as 
rats (Meredith et al. 1999), mice (Mao et al. 2001; Petroske et al. 2001) and humans 
(Porritt et al. 2000; Petroske et al. 2001; Cossette, Lecomte, and Parent 2005). Even 
though these neurons contain tyrosine hydroxylase, Xenias et al. found they lack the 
aromatic L-amino acid decarboxylase, dopamine transporter, VMAT2 and dopamine.  
Also, using voltammetry and optogenetics, they showed that these neurons do not release 
dopamine when stimulated (Xenias et al. 2015). 
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1.2.3. Inputs to Striatum 
 
The striatum integrates multiple inputs from other areas of the brain as well. The 
dorsal striatum receives glutamatergic inputs from the cortex, thalamus and amygdala.  
The nucleus accumbens receives glutamatergic inputs from cortex, amygdala and 
hippocampus.  There are also dopaminergic inputs originating from the substantia nigra 
and ventral tegmental area, which innervate the dorsal striatum and nucleus accumbens, 
respectively (Silberberg and Bolam 2015). The main GABA input to the striatum 
originates from the four classes of GABAergic interneurons as well as from axon 
collaterals originating from the MSNs.  Finally, there seems to be a small serotonergic 
input originating from the dorsal raphe.   
The corticostriatal glutamatergic input, which accounts for a majority of the 
inputs to both the D1-expressing and D2-expressing MSNs (Wall et al. 2013), has been 
shown to map topographically to the extended striatum. The majority of corticostriatal 
inputs from the frontal cortex, including the motor and sensory cortices, map to the 
dorsolateral striatum. The visual, cingulate and auditory cortices send projections to the 
dorsomedial striatum. Finally glutamatergic neurons from the limbic areas of the cortex 
send projections to the ventral striatum, including the nucleus accumbens (McGeorge and 
Faull 1989). A visual representation of the corticostriatal inputs is shown in Figure 2, 
using both coronal and sagittal sections.  
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1.3. Dopamine 
 
Dopamine is a neurotransmitter found in the brain that is important for voluntary 
motor control, motivation, reward, learning, attention and memory.  Two of the most 
studied dopaminergic nuclei of the brain are the substantia nigra pars compacta and the 
ventral tegmental area.  Each of these nuclei contains only about 20,000 dopamine 
neurons, but they have powerful effects on behavior.  This suggests that these neurons 
must have large projection fields to be able to influence brain activity.  In fact, dopamine 
neurons exhibit extensive arborizations in their terminal fields and each neuron can 
influence up to 6% of the striatal volume (Matsuda et al. 2009).  They fire tonically at 
about 5 Hz and signal through volume transmission which creates a basal dopaminergic 
tone in the projection areas (Tritsch et al. 2012).  The dopaminergic neurons are known to 
burst simultaneously for about 200 milliseconds when the subject is presented with a 
natural reinforcer or associated cues (Heien and Wightman 2006).   
The dopamine neurons of the VTA are one component of the reward pathway in 
the brain, which reinforces behavior that is necessary for survival such as eating, drinking 
and sex.  When a reward is presented, dopamine signaling increases (Schultz 2002).  This 
increase modulates circuits involved in memory and behavior, which ensures that these 
behaviors are repeated. 
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1.3.1. Volume Transmission 
 
Research suggests that dopamine is able to signal in the striatum via volume 
transmission. This type of communication is characterized by the ability of the 
neurotransmitter to diffuse in three-dimensions within the brain extracellular fluid beyond 
the synaptic cleft.  It differs from “wiring transmission” in that it does not occur within a 
well-defined structure as in synaptic transmission or communication through gap 
junctions. Release of neurotransmitter from one site is able to influence multiple target 
cells within a given sphere of influence.  Evidence that supports the idea of volume 
transmission includes the identification of release sites that are outside defined synapses 
and the presence of receptors located extra-synaptically. Usually volume transmission 
allows for a constant concentration of neurotransmitter to be present in the area in which 
it occurs (Agnati et al. 1995). 
Dopamine is believed to signal via volume transmission based on multiple pieces 
of evidence. Published data from no-net-flux micro-dialysis experiments in awake 
rodents report average baseline levels of dopamine in the low nano-molar range: average 
of 9.5 nM in rat dorsal striatum (Glick et al. 1994; S. R. Jones et al. 1998; Bianco et al. 
2008; Castner, Xiao, and Becker 1993; Chen, Lai, and Pan 1997; Martin-Fardon et al. 
1997; Sam and Justice 1996; A. D. Smith, Olson, and Justice 1992), 5.9 nM in mouse 
dorsal striatum (He and Shippenberg 2000; Käenmäki et al. 2010; Hewett et al. 2010), 4.5 
nM in rat nucleus accumbens (Crippens, Camp, and Robinson 1993; Glick et al. 1994; 
Parsons, Smith, and Justice 1991b; A. D. Smith and Weiss 1999; Kalivas and Duffy 
1993; Parsons and Justice 1992), and 4.8 nM in mouse nucleus accumbens (Zapata and 
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Shippenberg 2002; Käenmäki et al. 2010). Most (60-70%) of striatal dopaminergic 
varicosities are not associated with synaptic specialization (Descarries et al., 1996). It has 
also been observed that less than 10% of dopamine D1 and D2 receptors are associated 
with symmetrical synapses (Zoli et al. 1998). This ultrastructural observation coupled 
with amperometric experiments (Garris and Wightman 1994) suggests that dopamine 
signaling occurs through volume transmission. In fact, mathematical modeling suggests 
dopamine in the nucleus accumbens core is able to travel 6-12 μm before the 
concentration is reduced by half (Heien and Wightman 2006).  
 
1.3.2. Dopamine Transporter 
 
 The dopamine transporter (DAT) is a protein that is involved in the termination of 
the dopamine signal.  This protein binds dopamine in the extracellular space and moves it 
into the cytosol of the neuron.  In the striatum, this transporter is expressed on dopamine 
varicosities.  DAT functions as a symporter, and in order to function, must bind and co-
transport two sodium ions and a chloride ion along with a dopamine molecule 
(Mortensen and Amara 2003).   
DAT belongs to the SLC6 family of transporters that couple inward solute 
transport to downhill movement of Na
+
 and Cl
-
. This movement occurs as the protein 
cycles between an outward and inward conformation that bind the substrate and then 
release it on the opposite side of the membrane. The uptake rate and capacity of DAT are 
dependent on the kinetics of the conformation changes as well as the number of DAT 
present on the membrane surface (Vaughan and Foster 2013). 
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1.3.3. Psychostimulants 
 
 The dopamine transporter is a target of many drugs, including drugs of abuse, 
such as cocaine and amphetamine. Amphetamine is typically used to treat attention 
disorders, but is also abused. Cocaine can be used as a local anesthetic, but is also used 
for non-medical reasons. Both drugs cause hyperactivity in humans and rodents. These 
drugs are thought to exert their effects by blocking and/or reversing the dopamine 
transporter (Peña, Gevorkiana, and Shi 2015; Zhu and Reith 2008).  
Cocaine blocks the dopamine transporter, increasing the time dopamine is in the 
extracellular space. The presence of cocaine has been shown to increase the dopamine 
concentration up to 8-fold in the extended striatum (Camp, Browman, and Robinson 
1994; Church, Justice, and Byrd 1987). Amphetamine, on the other hand, is thought to 
exert its actions by not only preventing re-uptake of dopamine, but also by reversing the 
transporter, causing more dopamine to enter the synapse. Amphetamine has been shown 
to increase extracellular dopamine concentrations up to 30-fold of baseline in the striatal 
complex (Badiani et al. 1998; Carboni et al. 2001; Guan and McBride 1988).  
 Mounting evidence suggests that cocaine and amphetamine work through both 
dopamine transporter-dependent and independent mechanisms. Psychostimulants have 
also been shown to bind the serotonin and norepinephrine transporters (Han and Gu 
2006). Studies suggest that cocaine and amphetamine can still increase extracellular 
dopamine in the nucleus accumbens of dopamine transporter knockout mice (Carboni et 
al. 2001). The authors hypothesized that the presence of norepinephrine transporters 
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(NET) acted to clear the dopamine in DAT knockout mice in this case and were able to 
show that the addition of a NET blocker to the knockout animals increased extracellular 
dopamine in the nucleus accumbens of knockout animals but not wildtype. Further 
evidence shows that DAT knockout mice still self-administer cocaine and show cocaine-
induced place preference (Rocha et al. 1998; Sora et al. 1998). This suggests that while 
dopamine has been shown to play a role in the effects of psychostimulants, other 
pathways may also be involved.  
 
1.3.3. Dopamine D1-like Receptors 
 
Dopamine receptors are all G-protein coupled receptors and are divided into two 
classes: D1-like receptors (D1 and D5 receptors) or D2-like receptors (D2, D3 and D4 
receptors). D1-like receptors are coupled to Gαolf or Gαs, which activate adenylyl cyclase 
and lead to the production of cyclic AMP and activation of protein kinase A. The D1-like 
receptors are most abundant in the striatum and nucleus accumbens (Savica and 
Benarroch 2014).  
Binding studies of the D1 receptors has revealed that these receptors exist in a 
high and low affinity state for agonists. There are two theories to describe the affinity 
state of a G protein-coupled receptor. First, there is a theory that the G protein and 
receptor form a stable interaction regardless of binding state of the receptor. This 
interaction leads to a high affinity for the receptor, and, when bound to an agonist, the G 
protein activates effector proteins without dissociating from the receptor (Hein and 
Bünemann 2009; Qin et al. 2011). The second theory is the collision-coupling model, in 
13 
which the G protein and receptor are uncoupled and move freely throughout the cell 
membrane. When the receptor binds an agonist, it has a higher affinity for a G-protein, 
which then binds, activates and dissociates to activate effector proteins (Hein and 
Bünemann 2009; Skinbjerg et al. 2012). In general, it is believed that the D1 receptor 
exists mainly in a low affinity state and exhibits a Kd of about 1 μM for dopamine. 
Richfield et al. determined that about 80% of the D1 receptor exist in the low affinity 
state (Richfield, Penney, and Young 1989).  
 
1.3.4. Dopamine D2-like Receptors 
 
Dopamine D2-like receptors are coupled to Gαi/o, which inhibits adenylyl 
cyclase/cyclic AMP/PKA pathway, and phospholipase A2, which releases arachidonic 
acid. These signals can be terminated by either activation of a GTPase or phosphorylation 
of the receptor by a GPCR kinase (Savica and Benarroch 2014). D2-like receptors are 
found both presynaptically, where they function as autoreceptors, and postsynaptically.  
These receptors also have two distinct isoforms. The short form consists of 415 amino 
acids, and the long form has a 29 amino acid insertion in a domain between TM5 and 
TM6 (Dal Toso et al. 1989; Giros et al. 1989). Usiello et al. found that the long form of 
the receptor mainly exists on postsynaptic sites, whereas the short form mainly exists 
presynaptically and functions as an autoreceptor (Usiello et al. 2000). Like the D1 
receptors, the D2 receptors are most abundant in the striatum.  
It has also been shown that the D2 receptor exists in a high and low affinity state 
for agonists. Unlike the D1 receptors, the D2 receptors mainly exist in the high affinity 
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state with an Kd of about 10 nM for dopamine. Richfield et al. found that about 80% of 
the D2 receptor exist in the high affinity state (Richfield, Penney, and Young 1989). 
However, multiple studies of the number of high affinity D2 receptors in the striatum 
suggest the percentage of receptors ranges anywhere from 13-90% (van Wieringen et al. 
2012). This wide range could be due to multiple factors such as: agonist used, 
experimental protocol (intact cells vs. homogenates, composition of media) and analysis 
of the data (computer assisted vs. by hand). It is still not clear, though, whether the D2 
receptors exist in high and low affinity states in vivo and what the physiological 
significance is of the differing affinities (Skinbjerg et al. 2012). 
 
1.3.5. Modulatory Function 
 
Dopamine can only activate G protein-coupled receptors, meaning it cannot cause 
a direct change in the membrane potential of a neuron. Instead, dopamine serves a 
primarily modulatory role in the brain. When a D1 receptor is activated, it inhibits 
potassium channels and increases calcium currents. Activation can also increase the 
effects of glutamate on NMDA receptors, which further depolarize the membrane and 
aids in calcium influx. All of these effects usually lead to an increase in excitability for 
the cell. Another important target of the D1 receptor–activated pathway is DA- and cyclic 
AMP–regulated phosphoprotein of 32 kD (DARPP-32). DARPP-32 is a multifunctional 
protein that integrates multiple neurotransmitter signals to bi-directionally modulate PKA 
activity (Savica and Benarroch 2014). 
When D2 receptors are activated, the Gαi/o subunit inhibits the adenylyl 
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cyclase/cyclic-AMP/PKA pathway and promotes DARPP-32 dephosphorylation. The βγ 
subunits can also activate inwardly rectifying potassium channels and inhibit calcium 
channels. D2 activation has been shown to reduce the activity of NMDA receptors, as 
well.  When the D2 receptors are present on postsynaptic cells, these effects exert an 
inhibitory effect.  D2 receptors can also be found on presynaptically, where they decrease 
neurotransmitter release by inhibiting calcium channels (Savica and Benarroch 2014).
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Figure 1: Map of the Extended Striatum.  
A coronal section of one hemisphere of the extended striatum is shown above. The dorsal 
striatum is involved in motor coordination. The nucleus accumbens core and shell are 
involved in reward. Adapted from (Voorn et al. 2004).  
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Figure 2: Coronal and Sagittal Illustrations of Corticostriatal inputs.  
Using a color coordinate system, we have illustrated the locations of cortical neurons and 
the location of their projections within the striatum. Data on cell body and terminal field 
locations were extracted from studies of projections into the extended striatum (Britt et al. 
2012; Brown, Smith, and Goldbloom 1998; McGeorge and Faull 1989; Phillipson and 
Griffiths 1985; Sesack et al. 1989; Wall et al. 2013). We made a series of coronal (Figure 
2A) and sagittal (Figure 2B) sections and color-coded the striatal complex in blocks 
according to the following color scheme: low red shade indicates a medial position and high 
red shade indicates a lateral position; low green shade indicates a ventral position and high 
green shade indicates a dorsal position; and low blue shade indicates a caudal position and 
high blue shade indicates a frontal position.  We then indicated on coronal and sagittal 
sections with ovals showing location of cell bodies color-coded to have the same colors as 
their projection targets in the striatal complex. In the sagittal sections representing rat 
brains, the number in the lower right corner indicates mm lateral from the midline. In the 
coronal sections, the number in the lower right corner indicates mm in front of the interaural 
line (Wallace, LJ, unpublished).  
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Figure 2: Coronal and Sagittal Illustrations of Corticostriatal Inputs.  
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Figure 2 (Continued): Coronal and Sagittal Illustrations of Corticostriatal Inputs.  
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Figure 3: Volume Transmission vs. Wiring Transmission.  
This figure illustrates the differences between volume transmission, in which the 
neurotransmitter has the ability to diffuse within three-dimensional space and bind receptors 
on multiple neurons in the vicinity, and wiring transmission, in which a defined structure 
facilitates neurotransmission. Adapted from (Agnati et al. 1995). 
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Figure 4: Dopamine Receptor Signaling Pathways. 
Two types of dopamine receptors exist: the D1-like receptors and the D2-like receptors. D1-
like receptors are are coupled to Gαolf or Gαs, which activates adenylyl cyclase, which leads 
to the production of cyclic AMP and activation of protein kinase A. This has downstream 
effects that ultimately lead to increased excitability in the cell and contributes to synaptic 
plasticity. The D2-like receptors are coupled to Gαi/o, which inhibits adenylyl cyclase/cyclic 
AMP/PKA pathway, thus preventing the downstream effects of protein kinase A activation. 
The D2-like receptors can also decrease the excitability of potassium channels or block 
calcium channels and cause presynaptic inhibition via the βγ subunit. Adapted from (Savica 
and Benarroch 2014).  
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Chapter 2: Computational Modeling of Striatal Extracellular Dopamine Kinetics 
Suggests Low Probability of Neurotransmitter Release 
 
2.1. Introduction 
 
Dopamine signaling in the striatum and nucleus accumbens communicates 
novelty and saliency of the current environmental input and is involved in the learned 
formation of appropriate responses. Dopamine neurons from the ventral tegmental area 
(VTA) innervate the nucleus accumbens (ventral striatum), while dopamine neurons from 
the substantia nigra pars compacta (SNc) innervate the dorsal striatum.  The number of 
dopaminergic cell bodies in VTA and SNc is small, about 20,000-30,000 in mice and 
40,000-45,000 in rats (Björklund and Dunnett 2007); however, the axonal projections in 
the expanded striatum ramify extensively, forming dense, intricate axonal arborizations  
(Gauthier et al. 1999; Matsuda et al. 2009; Prensa and Parent 2001). The axonal tree from 
one neuron can influence up to 5.7% of striatal volume (Matsuda et al., 2009). 
Dopaminergic axons have varicosities (dopamine release sites) distributed along their 
axons within the expanded striatum, making an estimated 500,000 varicosities per neuron 
(Andén et al. 1966). Therefore, each dopaminergic neuron has the potential to exert a 
large influence in the striatum. Most (60-70%) of striatal dopaminergic varicosities are 
not associated with synaptic specialization (Descarries et al. 1996). This ultrastructural 
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observation coupled with amperometric experiments (Garris and Wightman 1994) 
suggest that dopamine signaling occurs through volume transmission. Thus, the 
neurotransmitter molecules can diffuse and affect receptors within a few micrometers of 
the release site. Dopamine is retrieved from the extracellular signaling compartment via 
the dopamine transporter (DAT) (Gether et al. 2006). Dopaminergic neurons fire 
intrinsically at about 1-5 Hz (Bunney, Aghajanian, and Roth 1973; Koeltzow et al. 1998), 
suggesting that a baseline dopaminergic tone is important to striatal function.   
Neuronal communication occurs when an action potential depolarizes a terminal 
membrane. This opens voltage gated calcium channels, which allows influx of calcium 
that interacts with storage vesicle membranes to stimulate the release of neurotransmitter 
(Catterall 2011). Control of timing and physical location of release is crucial to proper 
signaling. Release of a neurotransmitter is thought to be primarily controlled through the 
firing rate (frequency pattern of action potentials) of the neuron. However, several 
parameters at the axon terminal are capable of modulating the coupling of action 
potential to release of neurotransmitter. For example, activation of autoreceptors located 
on nerve terminals (Ford 2014) or activation of cannabinoid receptors on glutamatergic 
and GABAergic nerve terminals (Katona and Freund 2012) often decreases total 
neurotransmitter release. It is also possible that an action potential might not propagate 
throughout all of the axonal arborizations (Bucher and Goaillard 2011). 
Recent evidence suggests that dopamine secretion is not characterized by each 
action potential being associated with a high probability of full exocytotic release. In one 
study, measurement of dopamine released from cultured dopaminergic cells suggested 
that transient small synaptic vesicle fusion pores form, releasing about 25% of a vesicle’s 
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contents during each opening (Staal, Mosharov, and Sulzer 2004) In another study, 
dopamine storage vesicles were visualized using a false fluorescent neurotransmitter. The 
data suggested that 0.03 - 0.21% of dopamine synaptic vesicles fused in each stimulus, 
varying as a function of stimulation frequency (Gubernator et al. 2009). Previous 
simulation models performed in our lab also suggest that only a fraction of each vesicle is 
released during trains of electrical stimulation (Wallace and Hughes 2008).   
The first goal of the current study is to estimate the likelihood of full exocytotic 
dopamine release associated with each firing event under baseline conditions. This was 
done using a computer simulation model of an extracellular compartment associated with 
a dopaminergic varicosity. This model was then used to evaluate the relationships 
between dopamine release rate, DAT kinetics, and dopamine levels and compare model 
outputs to published data for striatal dopamine content, extracellular levels of dopamine 
measured by no-net-flux microdialysis, and DAT kinetics. Under baseline conditions, the 
results suggest that the amount of dopamine release occurring with each firing event is a 
small fraction of the contents of a single vesicle per varicosity. The second goal is to 
estimate the fraction of total stored dopamine released during a highly stimulated 
condition. This was done using the same model system to simulate published 
measurements of extracellular dopamine following electrical stimulation of striatal slices 
in vitro. The results suggest the amount of dopamine release induced by a single 
electrical stimulation may be as large as the contents of two vesicles per varicosity. 
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2.2. Materials and Methods 
 
2.2.1. Quantitative Parameters Relative to Dopamine Varicosities and Dopamine 
Transporter 
 
 The computer simulation model requires quantitative details describing dopamine 
varicosities and DAT kinetics. A summary of gross tissue level parameter values derived 
from published data is provided in Table 1. In the original publications, data are reported 
in a variety of different units (molar, pmol/mg protein, mg/gram wet weight, etc.). To 
facilitate comparisons, all data were converted to molar using conversion factors of 0.151 
mg protein/mg tissue, 0.084 mg membrane protein/mg tissue, tissue density of 1 g/mL, 
and molar mass of dopamine of 153 g/mole. Values for DAT Vmax vary substantially 
between different experimental paradigms. We chose to use the values from in vivo 
experiments in which Vmax was determined from rate of decline of dopamine after 
supramaximal stimulation of the medial forebrain bundle.  Values for DAT Km also vary 
substantially between different experimental paradigms. Values determined from rate of 
uptake of dopamine into transfected cells form one cluster, and those determined from 
rate of uptake of dopamine into brain tissue form another cluster. The transfected cell 
paradigm suffers from the disadvantage of not being neuronal tissue but has the 
advantage of being an intact system. The brain tissue paradigm suffers from the 
disadvantage of being a broken cell preparation (cell homogenates) or of being perturbed 
by the insertion of an electrode but has the advantage of being a neuronal system. Not 
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knowing which system most accurately resembles intact, undisturbed brain; we elected to 
examine effects using both values. 
 Our computations and simulation models examined parameters associated with a 
single varicosity containing a single release site. Therefore, gross tissue values were 
converted to numbers associated with the average for a single varicosity (assumes that all 
sites are identical) (Table 2). Some of our computations and simulation models compared 
dorsal striatum, nucleus accumbens core, and nucleus accumbens shell. However, data 
comparing varicosity density, dopamine levels, and DAT levels in nucleus accumbens 
core and shell are not abundant. The data that are available strongly support the concept 
that varicosity density, dopamine level, and DAT density are lower in nucleus accumbens 
than in dorsal striatum and that there is a gradient in these parameters from dorsal 
striatum to nucleus accumbens core to nucleus accumbens shell (Calipari et al. 2012; 
Cragg 2003; Mennicken et al. 1992). We chose to keep vesicle dopamine content and 
number of vesicles in a varicosity constant throughout the entire extended striatal 
complex, using the values calculated for dorsal striatum in both nucleus accumbens core 
and shell regions. We then calculated varicosity density and dopamine levels required to 
provide these numbers and noted they were in the ranges reported for nucleus accumbens. 
DAT catalytic rate was determined by dividing Vmax by DAT density. As this value was 
similar in striatum and nucleus accumbens, an average value was applied to all regions. 
To determine dopamine-DAT binding rate constants, we used MCell simulations of 
dopamine uptake assays in vitro. The association rate constant was varied (with 
dissociation rate constant set to 0) to find a value that produced a Km value from 
simulation data equal to each of the average Km values we averaged from published data. 
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The dissociation rate constant was arbitrarily chosen. Because it is about 1/20
th
 the value 
of the transport rate, it has no impact on any of the results.   
 
2.2.2. Simulation Model 
 
  Simulations of extracellular space associated with a dopaminergic varicosity 
were accomplished using MCell (Monte Carlo Cell), a stochastic simulation program that 
uses Monte Carlo algorithms to estimate molecule movement and reactions in three-
dimensional space (J. R. Stiles et al. 1996; J. Stiles and Bartol 2001; Kerr et al. 2008). 
The model has three sets of parameters. One is a morphology representing extracellular 
space through which dopamine can diffuse. Two models of extracellular space were 
evaluated. One was spherical with volume of 2.1x10
-15
 L (radius 0.79 μm) for the dorsal 
striatum, 3x10
-15 L (radius 0.89 μm) for the nucleus accumbens core and 7.7x10-15 L 
(radius 1.22 μm) for the nucleus accumbens shell model. The second model was a 
cylinder with volume of 2.1x10
-15
 L (radius 0.65 μm, height 1.58 μm) for the dorsal 
striatum, 3x10
-15 L (radius 0.73 μm, height 1.78 μm) for the nucleus accumbens core and 
7.7x10
-15
 L (radius 1.0 μm, height 2.44 μm) for the nucleus accumbens shell model. The 
second set of parameters characterized dopamine secretion into extracellular space. 
Dopamine was released from a point source on the surface of the spherical model and 
from a point source in the center of the end of the cylinder model. The third set of 
parameters characterizes dopamine removal by DAT. For the cylindrical model, DAT 
was arranged in a band of 0.75 microns width beginning 0.5 microns from the release site 
(Figure 5). For the cylindrical model, DAT was arranged in a band of 0.75 microns width 
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beginning at 0.5 microns from the end of the cylinder containing the release site. In 
MCell, transport is modeled as a binding reaction followed by a transport step: 
DA + DAT  DADATDA_TRANS + DAT 
DADAT represents the bound DA·DAT complex.  The second reaction simulates 
dopamine transport with a recycling of the transporter (DADAT), where DA_TRANS 
represents transported dopamine. Forward rate constants for the first reaction were either 
5x10
6
 or 1.3x10
8
 per molar per second (see Table 2), reverse rate was 0.5 per second, and 
rate constant for the second reaction was 9 per second. 
 For simulations of baseline level of dopamine, values for parameters were input 
into the model, and a pulse of dopamine was released every 0.2 seconds (simulating 5 Hz 
firing rate) or 1 second (simulating 1 Hz firing rate). The simulation was run for 
sufficient iterations to represent 30 seconds time, which produced a steady state level of 
extracellular dopamine. For simulations of effects of a single electrical pulse in brain 
slices, values for parameters were input into the model, and a pulse of dopamine was 
released at the beginning of the simulation. The simulation was run for sufficient 
iterations to represent 2-3 seconds.  
 
2.3. Results 
 
2.3.1. Models Assuming Release of Contents of a Single Vesicle 
 
 We first evaluated the hypothesis that each action potential releases the contents 
of one vesicle from each varicosity with each pulse. Using our computational model 
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simulating extracellular space surrounding a dopaminergic varicosity, the average level 
of extracellular dopamine was calculated using four different sets of conditions: firing 
rate of 1 and 5 Hz paired with a Kon of 5x10
6
 or 1.3x10
8 
M
-1
 sec
-1
. The simulation 
baseline dopamine ranged from 50 nM to micromolar levels (Table 3).  
Published data from no-net-flux micro-dialysis experiments in awake rodents 
report average baseline levels of dopamine in the low nano-molar range: average of 9.5 
nM in rat dorsal striatum (Bianco et al. 2008; Castner, Xiao, and Becker 1993; Chen, Lai, 
and Pan 1997; Glick et al. 1994; S. R. Jones et al. 1998; Martin-Fardon et al. 1997; Sam 
and Justice 1996; A. D. Smith, Olson, and Justice 1992), 5.9 nM in mouse dorsal striatum 
(He and Shippenberg 2000; Hewett et al. 2010; Käenmäki et al. 2010), 4.5 nM in rat 
nucleus accumbens (Crippens, Camp, and Robinson 1993; Glick et al. 1994; Kalivas and 
Duffy 1993; Parsons and Justice 1992; Parsons, Smith, and Justice 1991a; A. D. Smith 
and Weiss 1999), and 4.8 nM in mouse nucleus accumbens (Käenmäki et al. 2010; 
Zapata and Shippenberg 2002). Thus, the model output is large compared to the 
experimental data. This suggests that the hypothesis that contents of one vesicle are 
released from each varicosity at each firing event is wrong, suggesting release rate is 
much smaller than hypothesized.  
We also evaluated the hypothesis that each action potential releases the contents 
of one vesicle from each varicosity with each pulse from a slightly different point of 
view. If contents of a single dopaminergic storage vesicle are released every 0.2 seconds 
(5 Hz firing rate) and recaptured all at once, the recapture event would have to occur at 
0.001 seconds in order to produce an average extracellular dopamine concentration of 10 
nM.  This increases to 0.005 seconds at a 1 Hz firing rate. We then explored in our MCell 
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model conditions that would support such a rapid clearance. Increasing the rate constant 
for dopamine binding to DAT to the point where binding is diffusion limited failed to 
produce such rapid clearance. This observation suggests that release rate is much smaller 
than hypothesized. 
 
2.3.2. Models Estimating Dopamine Basal Release Rate 
 
The premise of this set of experiments is that the basal dopamine release rate can 
be estimated using computer simulation studies if the average baseline dopamine level, 
dopamine neuron firing rate, extracellular morphology and DAT kinetics are known. 
Using our simulation model, we determined the number of dopamine molecules released 
at each release event to produce an average extracellular dopamine level in our 
simulation output equal to that reported in no-net flux dialysis experiments. The results 
show a range from 2-400 molecules depending on the brain region, firing rate employed 
and Kon rate. This amounts to 0.1-21% of the estimated content of a vesicle.  Parameter 
values for simulations and corresponding dopamine release rates are shown in Tables 4 
and 5.  The release rate was the same for both the spherical and cylindrical morphologies. 
Since our estimated number of dopamine molecules in a vesicle is 1,900, the simulation 
results suggest that less than 25% of the contents of a vesicle is released at each firing 
event.  For dorsal striatum, we also ran simulations in which the entire contents of one 
vesicle were released every N action potentials, where 1/N is the percent of vesicle 
contents released in Tables IV and V. The average extracellular dopamine in these 
simulations was the same as that shown in Tables IV and V. For example, the 
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extracellular dopamine levels were 8 and 39 nM for 1and 5 Hz firing rates using the slow 
on-rate kinetics and a 1% release probability. 
 
2.3.3. Models estimating dopamine release under stimulated condition 
 
 This study was done to estimate dopamine release under conditions usually 
associated with a high rate of neurotransmitter secretion in order to estimate the fraction 
of stored dopamine released. We chose to simulate published experiments in which 
extracellular dopamine is measured using amperometric techniques following a single 
electrical pulse near a recording electrode in slices in vitro. The average peak dopamine 
concentration from such experiments was 1.74 μM for dorsal striatum, 1.13 μM for 
accumbens core, and 0.45 μM for accumbens shell. The number of dopamine molecules 
needed to provide these concentrations is 2,089, a number slightly larger than the 
contents of one vesicle.  
Published data for the effects of electrical stimulation of slices on extracellular 
dopamine levels monitor rate of decrease of dopamine after the stimulation pulse. Such 
data provided a reference to which we could compare our simulation model to validate 
that the parameters we used for estimating baseline dopamine levels are reasonable. For 
one set of simulations, total DAT per varicosity was fixed at 2,500, and the Vmax per 
transporter, kon binding rate parameters, and number of molecules released were varied 
until model output provided a good fit to published data for dorsal striatum (Fig. 6), 
nucleus accumbens core (Fig. 7), and nucleus accumbens shell (Fig. 8). Good matches to 
experimental data were obtained with Vmax values of 9-10 dopamine molecules/sec, kon of 
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1-2x10
6
 M
-1
sec
-1
, and 3,100 dopamine molecules released. The Vmax from these 
simulations was close to the value we calculated from published data (Table 2), and the 
kon value close to the lower affinity value calculated from published data (Table 2). For a 
second set of simulations, we fixed the kon to 1.3x10
8
 M
-1
sec
-1
, the value associated with 
the higher affinity value calculated from published data (Table 2), and varied Vmax value, 
number of available transporters, and number of dopamine molecules released. Good 
matches to experimental data were obtained with 330-375 transporters, 3,100 dopamine 
molecules released and Vmax value of 9-10 dopamine molecules/sec. These results 
suggest that a large range of sets of on rate and available transporter pairs produces 
output that fits the published experimental data. 
 
2.4. Discussion 
 
The first goal of the current study is to estimate the likelihood of full exocytotic 
dopamine release associated with each firing event under baseline conditions. Our 
simulation results using a variety of kinetic and firing rate parameters always showed a 
basal release rate of less than 25% of the contents of a single vesicle. The second goal is 
to estimate the amount of dopamine release during a highly stimulated condition. 
Simulation results suggest that the contents of up to 2 vesicles are released under these 
conditions. The conclusion of our paper is that dopamine release probability at any 
particular varicosity is low. This suggests that factors capable of increasing release 
probability could have a powerful effect on sculpting phasic dopamine signals.  
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2.4.1. Considerations relative to the simulation model 
 
The model, in essence, consists of three components: dopamine release, DAT, and 
morphology. Of these, the parameter that deviates most from reality is morphology. The 
ideal model would utilize an accurate morphology associated with a dopamine release 
site. Ultrastructural studies suggest the extracellular morphology is best approximated by 
a network of tubes with an average diameter of 35 nm (Thorne and Nicholson 2006). 
Given the extracellular volume of 2.1 μm3 associated with each varicosity in the dorsal 
striatum, the network would have a total length of 2180 μm. Within this network, DAT 
would be located in clusters somewhat close to the dopamine release site. A number of 
“tubes” would be branching away from the release site, some from locations between the 
release site and DAT and others distal to the cluster of DAT. Accurately modeling such a 
complicated morphology requires extensive ultrastructural studies on extracellular space 
in the striatum and substantial computational power. We chose to utilize simpler models 
for our study. In our model, we used two morphologies: a sphere and a cylinder. Our 
comparison of these two morphologies showed that morphology had little, if any, impact 
on our results (Tables 4 and 5). In an additional evaluation of morphology, we reduced 
the size of the extracellular space to one-third the original volume. This would evaluate 
the possibility that dopamine might not diffuse into spaces farther from the release site. 
This simulation yielded identical results (data not shown) to those reported in Table 4 and 
5. We found the reason for this lack of impact of geometry on the results is that dopamine 
diffusion rate is much faster than the rate of dopamine binding to DAT. Based on this, we 
believe our conclusion is valid in spite of limitations of using a simplified morphology.  
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For DAT kinetics, we tested multiple values for both the association rate and 
turnover rate.  Under all conditions tested, at most 25% of a single vesicle was required to 
match baseline extracellular dopamine as measured by no-net-flux dialysis. The 
conclusion that dopamine release probability at any particular varicosity is low was 
consistently observed under multiple kinetic conditions. The evaluation done with the 
faster on rate and 2,800 DAT would be close to maximum rate at which dopamine could 
possibly be removed as this on rate approaches the value at which binding would be 
diffusion limited. Several studies show that DAT transitions between a plasma membrane 
location and an intracellular location (Melikian 2004), suggesting that fewer DAT are 
available for actually transporting dopamine than used in our simulation model. Thus, our 
simulations using all of the DAT available for transport are biased towards higher levels 
of dopamine release, which provides additional support to the conclusion that dopamine 
release probability is low.  
In our analysis of electrically stimulated dopamine release in brain slices, the 
estimate of release of contents of approximately two vesicles necessary for our model to 
match published data were independent of dopamine transporter kinetics (Figs. 6-8). Two 
extremes of possible kinetics were used in these studies: maximum number of available 
transporters paired with a slower on-rate for dopamine binding to DAT and maximum 
on-rate for dopamine binding to DAT paired with fewer available transporters. As 
binding data for the transporter does not distinguish between surface and internalized 
protein; we cannot be certain how many transporters are present and capable of moving 
dopamine at any given time. Each model, regardless of the kinetic parameters, required 
the release of contents of about two vesicles of dopamine per varicosity to match the 
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voltammetry data. The maximum extracellular dopamine concentration in these 
experiments was in the ballpark of 1 μM, a level approximately 100-fold higher than the 
estimated baseline dopamine level in vivo. Extrapolating from this comparison suggests 
that about 2% of the contents of a vesicle in each varicosity is released with each firing 
event under baseline in vivo conditions, further supporting our conclusion that dopamine 
release probability is low.  
The strength of our conclusion also depends on the validity of the data we used 
for extracellular dopamine levels. For example, if the 5-10 nM level reported for no-net-
flux dialysis underestimates the true concentration of extracellular dopamine, then our 
simulation model also underestimates the rate of dopamine release. While no-net-flux 
dialysis data for baseline levels of extracellular dopamine are very consistent, some other 
methods have provided higher values. For example, a drop of several hundred nanomolar 
in extracellular dopamine levels (measured using amperometry technique) was observed 
after administration of kynurenate (Kulagina, Zigmond, and Michael 2001). However, 
other studies using amperometry have not provided support for higher levels of basal 
extracellular dopamine. For example, a study directly examining baseline extracellular 
dopamine using fast scan cyclic voltammetry in vivo in awake animals provided robust 
data for an average extracellular dopamine level of 20-30 nM in nucleus accumbens 
(Owesson-White et al. 2012). Another argument for low levels of baseline extracellular 
dopamine derives from studies of effect of activation of dopamine D2 receptors on 
electrically stimulated dopamine release from striatum and nucleus accumbens in slices. 
Such studies consistently document that saturation of D2 receptors blocks dopamine 
release (Bello et al. 2011; Benoit-Marand, Borrelli, and Gonon 2001; Kennedy, Jones, 
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and Wightman 1992). This suggests that baseline dopamine levels must be sufficiently 
low that D2 receptors are not activated.  
In addition to our modeling data, some experimental data have been consistent 
with the concept that only a small fraction of dopamine molecules in a single storage 
vesicle is released under baseline conditions. For example, measurement of dopamine 
released from cultured dopaminergic cells suggested that transient small synaptic vesicle 
fusion pores form, releasing about 25% of a vesicle’s contents during each opening 
(Staal, Mosharov, and Sulzer 2004). In another study, dopamine storage vesicles were 
visualized using a false fluorescent neurotransmitter. The data suggested that 0.03 - 
0.21% of dopamine synaptic vesicles fused in each stimulus, varying as a function of 
stimulation frequency (Gubernator et al. 2009). These data support our conclusion.  
 
2.4.2. Implications of the results 
 
From a mathematical perspective, a low probability of dopamine release can be 
accomplished through more than one mechanism. These include each firing event 
stimulating full exocytotic release of a single vesicle at a fraction of varicosities, kiss and 
run mechanism resulting in partial release of contents of a single vesicle at each 
varicosity, kiss and run mechanism resulting in partial release of contents of a single 
vesicle from some fraction of total varicosities, and release of dopamine from a non-
vesicular pool. Data shown in this paper are from simulation models compatible with the 
condition that a small percent of the contents of every vesicle is released at each firing 
event. We also ran simulation models of the condition that the entire contents of a vesicle 
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are released at a small percent of firing events. The results yielded average baseline 
dopamine levels in the low nano-molar range.  Thus, we cannot conclude from our 
simulation models which mechanism is functional in the brain. 
From a biochemical perspective, several mechanisms could produce a low 
probability of dopamine release. One possibility is the existence of silent dopaminergic 
neurons that are not actively secreting neurotransmitter under baseline conditions. Some 
electrophysiological studies suggest that about half of dopaminergic neurons in the 
nucleus accumbens are not active in a normal, quiescent animal (Grace et al. 2007), while 
other studies suggest all dopaminergic neurons are tonically active (Dai and Tepper 
1998). Another possibility is that all neurons are active but that action potentials do not 
propagate throughout the extensive axonal trees. Dopaminergic fibers are thin and 
unmyelinated, characteristics consistent with lesser action potential propagation 
capabilities (Pissadaki and Bolam 2013). At this point, we are not aware of studies 
measuring signal propagation in multiple branches of dopaminergic neurons. A third 
possibility is that release machinery is not responsive to depolarization under baseline 
conditions because of a low density of voltage-gated calcium channels. One could then 
hypothesize that the presence of signals acting at the release site to induce calcium influx 
could modulate the effects of dopamine neuron firing. One potential signal is activation 
of nicotinic acetylcholine receptors. Binding and functional data suggest that nearly every 
dopaminergic varicosity contains a nicotinic acetylcholine receptor (I. W. Jones, Bolam, 
and Wonnacott 2001). Activation of such receptors might further depolarize the 
membrane above the level induced by an action potential, allowing for dopamine release. 
Studies employing nicotinic agonists and antagonists have shown varying effects on 
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dopamine release. However, a study using optogenetics to study the effect of cholinergic 
interneuron activation clearly documents that activation of a population of cholinergic 
interneurons elicits dopamine release in vivo in the absence of any other stimulus. This 
dopamine release was nicotinic receptor dependent and frequency independent (Threlfell 
et al. 2012). 
A very low baseline dopamine signal coupled with the ability to sculpt local 
dopamine release at the terminal level has interesting implications relative to the function 
of the extended striatal complex. The extended striatal complex receives inputs from 
across the entire volume of the cerebral cortex in a topographical manner modified by 
function such that cortical areas controlling different modalities of a behavior project to 
the same striatal area (Voorn et al. 2004). Thus, the global dopamine signal might 
indicate the saliency and novelty of current sensory information, while local signals 
provide a sculpted phasic dopamine response corresponding to the particular behavior or 
emotion where learning/behavioral change needs to occur. Thus, the global firing 
dopamine signal set by the firing rate/pattern sets a tone on top of which local signals 
drive specific behaviors. This might be a component of the mechanisms used to fine tune 
behaviors to maximize well-being. 
In summary, dopamine signaling in the striatum and nucleus accumbens 
communicates novelty and saliency of the current environmental input and is involved in 
learned formation of appropriate responses. The tonic, or baseline, dopamine signal 
results from a regular firing of dopamine neurons at approximately 1-5 Hz. The 
conclusion of our paper is that at these baseline conditions dopamine release probability 
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at any particular varicosity is very low. This suggests that factors capable of increasing 
release probability could have a powerful effect on sculpting phasic dopamine signals.  
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Table 1. Parameter values derived from biochemical data 
Parameter Value 
Dopamine level (striatum) 79.2 μM a 
Dopamine level (accumbens) 50.9 μM b 
Dopamine varicosity density (striatum) 1x10
+8
/mm
3 c
 
Dopamine varicosity density (accumbens) 2-6x10
+7
/mm
3 d
 
Dopamine transporter level (striatum) 0.47 μM e 
Dopamine transporter level (accumbens) 0.21 μM f 
Dopamine transporter Vmax (striatum) 4.08 μM/sec g 
Dopamine transporter Vmax (accumbens) 2.14 μM/sec h 
Dopamine transporter Km (transfected cells) 2.17 μM i 
Dopamine transporter Km (tissue prep) 0.2 μM j 
a
 Derived from (Bardullas, Giordano, and Rodríguez 2011; Abekawa et al. 2001; Buu 
1989; Cartmell et al. 2000; Gao and Dluzen 2001; Miller, Shore, and Clarke 1980; 
Ponzio et al. 1984; Takahashi et al. 1997; Sharp, Zetterström, and Ungerstedt 1986; 
Vezina et al. 1992; Yu, Kuo, and Cherng 2001; Yuan et al. 2001) 
b
 Derived from (Bardullas, Giordano, and Rodríguez 2011; Cartmell et al. 2000; Fitoussi, 
Dellu-Hagedorn, and De Deurwaerdère 2013; Sharp, Zetterström, and Ungerstedt 1986; 
Vezina et al. 1992; Westerink and Korf 1976) 
c
 Derived from (Doucet, Descarries, and Garcia 1986) 
d
 Derived from (Doucet, Descarries, and Garcia 1986; Zhou et al. 2006) 
e
 Derived from (Boja et al. 1995; Bonnet et al. 1986; Chen, Lai, and Pan 1997; 
Dubocovich and Zahniser 1985; Erikson, Jones, and Beard 2000; Garreau et al. 1997; 
Hooks, Juncos, et al. 1994; Janowsky et al. 1986; Marshall et al. 1990; Moll et al. 2000; 
Nakayama, Koyama, and Yamashita 1993; Rothman et al. 1994) 
f 
Derived from (Bonnet et al. 1986; Erikson, Jones, and Beard 2000; Hooks, Juncos, et al. 
1994; Janowsky et al. 1986; Marshall et al. 1990) 
g
 Derived from (Garris and Wightman 1994; May and Wightman 1989; Wu et al. 2001) 
h
 Derived from (Garris and Wightman 1994; May and Wightman 1989; Wu et al. 2001) 
i
 Derived from (Carneiro et al. 2002; Chang et al. 2001; Eshleman et al. 1995; Itokawa et 
al. 2000; Kitayama et al. 1992; Lee et al. 1996; Lin and Uhl 2002; C. J. Loland, 
Norregaard, and Gether 1999; Claus Juul Loland et al. 2002; Lin and Uhl 2005) 
j 
Derived from (Horn 1990; Marshall et al. 1990; Wu et al. 2001; Harris and Baldessarini 
1973; Near, Bigelow, and Wightman 1988; Rothman et al. 2001; S. H. Snyder and 
Coyle 1969) 
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Table 2. Parameter values associated with a single varicosity. 
Parameter Value 
Number of dopamine molecules per varicosity 475,000 
Number of vesicles per varicosity 250 
Number of dopamine molecules per vesicle 1,900 
Extracellular volume associated with a release site (dorsal 
striatum) 
2x10
-15
 liter 
Extracellular volume associated with a release site (accumbens 
core) 
3.1x10
-15
 liter 
Extracellular volume associated with a release site (accumbens 
shell) 
7.7x10
-15
 liter 
Number of DAT associated with a release site 2,800 
DAT catalytic rate 9 /sec 
DAT-DA binding on-rate (transfected cells) 5x10
+6
 M
-1
sec
-1 
DAT-DA binding on-rate (tissue prep) 1.3x10
+8
 M
-1
sec
-1
 
DAT-DA binding off-rate 0.5 sec
-1
 
Dopamine diffusion rate 4x10
-6
 cm
2
/sec 
a
 
a
 Derived from (Land et al. 1984; Rice and Cragg 2008; Schönfuss et al. 2001) 
 
 
 
 
 
 
 
 
 
 
 
 
 42 
Table 3. Extracellular dopamine levels with full vesicle release 
Firing Rate  Dopamine Level 
  Kon=5x10
6
 M
-1
 sec
-1
 Kon=1.3x10
8 
M
-1
 sec
-1
 
1 Hz 770 nM 50 nM 
5 Hz Continually increasing 300 nM 
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Figure 5: Visualization of the location of DAT on the spherical model of extracellular 
space associated with a dopaminergic varicosity.  
The sphere has a diameter of 0.79 µm, and dopamine is released from a point source at the 
top of the sphere. Black dots represent DAT molecules, of which there are 2,500 in this 
model. 
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Table 4. Estimated rate of basal dopamine release in simulation models
1
. 
Region Concentration
2
 
Firing 
Rate 
Release 
Rate
3
 
Dorsal 
Striatum 
8 nM 1 Hz 100 
8 nM 5 Hz 20 
Nucleus 
Accumbens 
Core 
4 nM 1 Hz 50 
4 nM 5 Hz 10 
Nucleus 
Accumbens 
Shell 
4 nM 1 Hz 50 
4 nM 5 Hz 10 
1
 Simulations used a spherical morphology, 2,800 total DAT molecules with a transport 
rate of 9 dopamine per second and an on-rate of dopamine binding to DAT of 5x10
6 
M
-1
 
sec
-1
. 
2
average dopamine concentration from the simulation output  
3
release rate is number of dopamine molecules released per firing event to produce the 
average extracellular dopamine concentration listed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 45 
Table 5. Estimated rate of basal dopamine release in simulation models
1
. 
Region Concentration
2
 
Firing 
Rate 
Release 
Rate
3
 
Dorsal 
Striatum 
9 nM 1 Hz 400 
9 nM 5 Hz 100 
Nucleus 
Accumbens 
Core 
4 nM 1 Hz 175 
4 nM 5 Hz 40 
Nucleus 
Accumbens 
Shell 
4 nM 1 Hz 200 
5 nM 5 Hz 50 
1
 Simulations used a spherical morphology, 2,800 total DAT molecules with a transport 
rate of 9 dopamine per second and an on-rate of dopamine binding to DAT of  
1.3x10
8
 M
-1
 sec
-1
.
 
2
average dopamine concentration from the simulation output  
3
release rate is number of dopamine molecules released per firing event to produce the 
average extracellular dopamine concentration listed. 
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Figure 6:  Simulation model output compared to published data for which rate of 
dopamine disappearance was measured as a function of time after electrical 
stimulation in dorsal striatum in brain slices in vitro.  
Simulation parameter values for sim-fix number were 2,500 transporters kon=1.5x10
6
 
M
-1
sec
-1
, Vmax = 10 dopamine molecules/sec, and 3,100 dopamine molecules released. 
Simulation parameter values for sim-fast on were 300 transporters kon=1.3x10
8
 M
-1
sec
-1
, 
Vmax = 10 dopamine molecules/sec, and 3,100 dopamine molecules released. The 100% 
value = 1.735 μM. Published data are from (Anzalone et al. 2012; Bello et al. 2011; 
Birbeck, Khalid, and Mathews 2014; Hnasko et al. 2010; S. R. Jones et al. 1998; S. R. Jones 
et al. 1999; Y Schmitz et al. 2001; L. Zhang et al. 2009; Perez et al. 2010). We noted that 
two sets of experimental data differed substantially from the majority, and these are 
indicated by open symbols. 
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Figure 7: Simulation model output compared to published data for which rate of 
dopamine disappearance was measured as a function of time after electrical 
stimulation in nucleus accumbens core in brain slices in vitro.  
Simulation parameter values for sim–fix number were 2,500 transporters kon=1.75x10
6
 
M
-1
sec
-1
, Vmax = 9 dopamine molecules/sec, and 3,100 dopamine molecules released. 
Simulation parameter values for sim–fast on were 300 transporters kon=1.3x10
8
 M
-1
sec
-1
, 
Vmax = 9 dopamine molecules/sec, and 3,100 dopamine molecules released. The 100% 
value = 1.126 μM. Published data are from (Ferris et al. 2012; Ferris et al. 2011; Mateo et 
al. 2004; Siciliano et al. 2014; Yorgason et al. 2014; L. Zhang et al. 2009). 
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Figure 8: Simulation model output compared to published data for which rate of 
dopamine disappearance was measured as a function of time after electrical 
stimulation in nucleus accumbens shell in brain slices in vitro.  
Simulation parameter values for sim–fix number were 2,500 transporters, kon=2x10
6
 
M
-1
sec
-1
, Vmax = 9 dopamine molecules/sec, and 3,100 dopamine molecules released. 
Simulation parameter values for sim–fast on were 375 transporters, kon=1.3x10
8
 M
-1
sec
-1
, 
Vmax = 9 dopamine molecules/sec, and 3,100 dopamine molecules released. The 100% 
value = 0.453 μM. Published data are from (Adrover, Shin, and Alvarez 2014; Fawaz et al. 
2009; Mateo et al. 2004; Patyal, Woo, and Borgland 2012; Perez et al. 2010; L. Zhang et al. 
2009). We noted that one set of experimental data differed substantially from the majority, 
and this is indicated by open symbols. 
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Chapter 3: Quantitative View of the Striatal Complex 
 
3.1. Introduction 
 
The extended striatum, consisting of regions called dorsal striatum, nucleus 
accumbens core, nucleus accumbens shell, and possibly olfactory tubercle, plays a major 
role in learning, motivation, and development of habits. The individual components of 
the striatal complex have been extensively studied. A number of review articles have 
been published, focusing on various parameters such as functions regulated by the striatal 
complex, cell types found within the complex, connections into and out from the 
complex, electrophysiological perspectives, and molecules located within the complex. 
One perspective that has not been reviewed is quantitative details of number of 
varicosities and receptors; therefore, this review provides a quantitative picture of these 
aspects of the striatal complex. This information is useful for making inferences about 
signaling and functional regulation. 
 
3.1.2. Striatal Neuron Subtypes 
 
In this review, we begin with a brief overview of the cell types present in the 
striatal brain region.  The most abundant neurons of the striatum, the medium spiny 
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neuron (MSN), comprise 90-95% of total neurons in this region (Graveland and Difiglia 
1985; Gerfen and Wilson 1996).  The name derives from the moderate density of spines 
on their dendritic processes. MSNs send projections along two distinct pathways.  One 
projection, known as the direct pathway, sends fibers to the globus pallidus 
interna/substantia nigra pars reticulata, and neurons comprising this pathway express 
dopamine D1 receptors.  The indirect pathway sends projections to the globus pallidus 
externa, and neurons in this pathway express dopamine D2 receptors.  There is only a 5-
15% overlap of expression of D1/D2 receptors in adult MSNs, thus allowing for a distinct 
segregation of the two pathways (Cerovic et al. 2013). MSNs utilize GABA and several 
peptides as neurotransmitters. As the MSN are the only outputs from the striatal complex, 
the computational integration that occurs in this brain region is entirely expressed in their 
firing pattern. The MSNs are intrinsically quiet (Wilson and Kawaguchi 1996); therefore, 
their activity pattern is determined by glutamatergic inputs and subsequent modification 
within dendritic structures of the elicited depolarizing signals. 
In addition to axons projecting out of the striatum, all MSNs have 5-10 collateral 
axons synapsing within the striatum (Wilson and Groves 1980). On average, these 
collaterals, which branch extensively, are between 200 and 500 μm long when measured 
in the rat nucleus accumbens shell (van Dongen et al. 2008). The collaterals target the 
majority of MSNs and tonically active (cholinergic) interneurons (Chuhma et al. 2011). 
The other 5% of neurons present in the striatum consist of interneurons: four 
classes of GABAergic interneurons as well as cholinergic interneurons. Cholinergic 
interneurons account for 1-2% of total neurons in this brain region.  Axons of cholinergic 
interneurons in the striatum branch profusely (Contant et al. 1996), and it is not clear 
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what proportion of branches are dendrites and are axons. Cholinergic interneurons are 
tonically active (Bennett and Wilson 1999), providing a constant basal level of 
acetylcholine in the extracellular environment. As the only other cholinergic innervation 
into the striatum is a very small tract from the pedunculopontine nucleus (Dautan et al. 
2014), the vast majority of cholinergic synapses arise from the interneurons.   
The remaining interneurons are GABAergic in nature and are divided into four 
subclasses based on their electrophysiological properties. The subclasses are the fast 
spiking GABAergic interneurons, the low threshold spiking interneurons, the calretinin 
positive GABAergic interneurons (Tepper and Bolam 2004), and tyrosine hydroxylase 
positive GABAergic interneurons (Ibáñez-Sandoval et al. 2010). The fast spiking 
neurons, which are also characterized by their expression of parvalbumin, are thought to 
make up about 0.7% of the total neurons in the rat striatum (Luk and Sadikot 2001) and 
are electrotonically coupled via gap junctions (Kita, Kosaka, and Heizmann 1990). The 
fast spiking interneurons receive a glutamatergic input from the cortex as well as 
GABAergic input from MSN axon collaterals and a cholinergic input (Tepper and Bolam 
2004). The low threshold spiking interneurons express neuropeptide Y, somatostatin and 
nitric oxide synthase (Y. Smith and Parent 1986). These neurons account for about 0.8% 
of neurons in the rodent striatum (Rymar et al. 2004) and have the least dense axonal 
arborization (Kawaguchi 1993). The calretinin neurons account for about 0.8% of 
neurons in rodent striatum (Rymar et al. 2004) and are relatively sparse in the caudal 
areas of the striatum (Bennett and Bolam 1993). There are currently no 
electrophysiological data for these cells, so their profile is not known. Finally, the 
tyrosine hydroxylase GABAergic interneurons are further divided into four subclasses 
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based on their electrophysiological profiles. They were first described in 1987 in the 
primate (Dubach et al. 1987) and since then have been described in other species such as 
rats (Meredith et al. 1999), mice (Mao et al. 2001; Petroske et al. 2001) and humans 
(Porritt et al. 2000; Petroske et al. 2001; Cossette, Lecomte, and Parent 2005). Even 
though these neurons contain tyrosine hydroxylase, they lack the aromatic L-amino acid 
decarboxylase, dopamine transporter, VMAT2 and dopamine and do not release 
dopamine when stimulated (Xenias et al. 2015). 
 
3.2. Striatal Inputs/neuronal pathways 
 
All areas of the striatal complex appear to have three sets of glutamatergic inputs 
that can activate striatal output neurons. One input is from the cerebral cortex, with 
ventral areas of the striatal complex receiving input from anterior portions of the cortex 
and dorsal portions of the striatum receiving input from posterior aspects of the cortex. A 
second input is from amygdala. The third input is from thalamus for dorsal regions of 
striatal complex and from ventral hippocampus for ventral regions of the striatal 
complex. Dopaminergic neurons in the ventral tegmental area (VTA) and substantia nigra 
pars compacta (SNc) also send inputs to the nucleus accumbens and dorsal striatum, 
respectively. A small GABAergic/ enkephalinergic input originates from the external 
globus pallidus (Mallet et al. 2012) as well as a small GABAergic pathway from VTA to 
accumbens (Van Bockstaele and Pickel 1995).  
Statistically speaking, these inputs most likely synapse on MSNs. These neurons 
have a large, densely branching dendritic tree. Typically, 3-6 parent dendrites on average 
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emanate from the cell body of each medium spiny neuron (Kincaid, Zheng, and Wilson 
1998). These primary dendrites split approximately 20 μm from the cell body into 
secondary and tertiary branches. In the rat nucleus accumbens the dendrites extend up to 
750 μm from the cell body (Meredith et al. 1992), and the average total length of the 
dendrites for the shell and core is 1,453 μm and 2,425 μm, respectively. The extensive 
length of the dendrites suggests that each neuron possesses a large number of inputs. 
Varicosities/release elements can be counted in various histological and electron 
microscopic studies. Specific markers are sometimes used to associate varicosities/release 
sites with various neurotransmitter systems. For glutamate, three different markers have 
been used. Since the vast majority of glutamate synapses form at spine heads, the 
number/density of dendritic spines serves as an index of glutamatergic inputs. The 
VGlut1 and VGlut2 transporter proteins also serve as markers of glutamatergic inputs. In 
the striatal complex, these markers segregate, with VGlut1 localized to inputs from 
cortical areas and VGlut2 localized to inputs from subcortical areas (R. T. Fremeau et al. 
2001; Robert T. Fremeau et al. 2004). The VGAT transporter protein serves as a marker 
for GABAergic inputs, the ChAT enzyme involved in the synthesis of acetylcholine 
serves as a marker for cholinergic inputs, the TH enzyme involved in catecholamine 
synthesis and the DAT transporter serve as markers for dopaminergic inputs, and the 
SERT transporter serves as a marker for serotonin inputs. We are not aware of good 
markers for opioid and other peptide neurotransmitters. We collated data from several 
different laboratories using a variety of techniques to count varicosities and inputs into 
Table 6. The fact that the number of glutamatergic inputs closely matches the spine 
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density and that the total number of inputs determined from counting total varicosities 
and the sum of specialized components are close suggests that estimates are reliable.  
Since the medium spiny neurons account for more than 90% of the neurons in the 
striatum and their large dendritic trees suggest many inputs, statistically assigning inputs 
to associate with medium spiny neurons should be relatively accurate. This is done by 
dividing the density of varicosities/release sites by the density of cells in the striatum, 
80,000 per mm
3
 (Antipova et al. 2013; Oorschot 1996; Humphries, Wood, and Gurney 
2010; Zheng and Wilson 2002), which is a close approximation of the density of medium 
spiny neurons in the striatum. Table 6 summarizes our findings.  
The large number of inputs per neuron (12,500) suggests that each neuron in the 
striatum functions as a major integration center to provide a single output. The sheer 
number of inputs per neuron implies that no single input is sufficiently privileged to be 
able to initiate an axon potential. Thus, induction of an action potential likely requires 
simultaneous activation of many glutamatergic inputs. The vast array of inhibitory 
GABA inputs and modulatory acetylcholine and dopamine inputs provides the 
anatomical substrate for a substantial number of patterns of modulation. About half of the 
inputs to each neuron are glutamatergic in nature. Of these, about 60% originate from the 
cortex and 40% from subcortical areas. While we speculate that normally the generation 
of action potentials requires activation of inputs from all three glutamatergic pathways, 
each pathway has sufficient connectivity to drive action potentials when maximally 
stimulated (Britt et al. 2012). The large branching dendritic tree with many inputs may 
provide substantial computational power, as well. It is possible that dendritic branches 
each serve as a computational unit. A recent paper measured the changes in spine density 
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during learning and found that new spines were localized to a single dendritic branch 
(Yang et al. 2014). 
Another interesting observation from these data is that the number of serotonin 
varicosities is on the order of 100-fold lower than the levels of any other input. If 
serotonin is to have any functional impact on medium spiny neurons, the inputs would 
have to be located on or very close to the cell body. A very likely alternative is that the 
serotonin inputs preferentially innervate one of the classes of interneurons. 
Although the striatum is considered to be a dopaminergic area, the dopaminergic 
inputs only account for about 10% of the total inputs to a medium spiny neuron. In 
referring to the dopamine system, the striatum is dopaminergic in that it contains far more 
dopamine than other brain regions. Thus, the term “dopaminergic” refers to comparisons 
of amount of dopamine between brain areas rather than to a comparison of amount of 
dopamine with other neurotransmitters in the striatal region. Relative to the latter, a 
comparison of dopamine and acetylcholine is interesting. Tissue levels of dopamine in 
the striatum are about 80 μM (Miller, Shore, and Clarke 1980; Ponzio et al. 1984; Sharp, 
Zetterström, and Ungerstedt 1986; Buu 1989; Vezina et al. 1992; Takahashi et al. 1997; 
Cartmell et al. 2000; Abekawa et al. 2001; Gao and Dluzen 2001; Yu, Kuo, and Cherng 
2001; Yuan et al. 2001; Bardullas, Giordano, and Rodríguez 2011), which is only slightly 
larger than the average tissue acetylcholine concentration of 53 μM (Carta et al. 2006; 
Euvrard et al. 1977). In contrast, the comparative amounts of release sites shows the 
opposite order, number of cholinergic release sites is double that of dopaminergic release 
sites.  In comparing another parameter, each cholinergic interneuron in the striatum has, 
on average, 500,000 axon varicosities (Contant et al. 1996), and each dopamine neuron 
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has, on average, 500,000 varicosities per neuron in the striatum (Andén et al. 1966). This 
suggests that there is double the number of cholinergic interneurons to dopamine neurons 
innervating the striatum.  
The varicosities described in Table 6 include both synaptic and non-synaptic 
inputs, which influences how each neurotransmitter signals within the striatum. 
Glutamate and GABA inputs are predominantly synaptic, which means these 
neurotransmitters signal within a defined synapse. The signaling molecules are confined 
to the synapse, which is typically ensheathed by glial cells and is only about 20 
nanometers wide (Zuber et al. 2005). Glutamate and GABA are the main excitatory and 
inhibitory signals in the central nervous system. These neurotransmitters activate ion 
channels on the postsynaptic cell and can depolarize or hyperpolarize the cell membrane. 
Dopamine and acetylcholine, however, signal via an extrasynaptic mechanism, and a 
majority of the inputs do not form defined synapses within the striatum. These 
neurotransmitters signal via a mechanism known as volume transmission, in which they 
can diffuse a few microns from the release site and influence the membrane potential and 
ionotropic receptors via G-protein coupled receptors and second messenger systems in a 
“neighborhood” around the release sites.  
 
3.3. Receptors in Striatum  
 
In order for neuronal communication to occur, receptors must be present to 
receive the signal from the varicosities and synapses. The majority of receptors involved 
in neuronal communication in the striatum fall into two classes, ion channels or G 
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protein-coupled receptors. Ion channels act as a pore that, when activated, allows for the 
flow of ions through the membrane and can either depolarize or hyperpolarize the 
membrane. G protein-coupled receptors, when activated, initiate a signaling cascade 
within the cell that may indirectly alter the potential of a segment of neuronal membrane 
or the gating properties of the ion channels. Glutamate, GABA, and acetylcholine 
activate the ion channel receptors known to be in the striatum. The modulatory G protein-
coupled receptors for which we found data in the striatum include acetylcholine, 
dopamine, opioid peptides, and endogenous cannabinoids. Table 7 shows binding data for 
receptors present in the striatum. 
The most abundant receptor is CB1. This is interesting given that the endogenous 
cannabinoid molecules are not stored but are made on demand. Muscarinic receptors are 
a close second. Dopamine receptor density is about half of the muscarinic receptor 
density, reinforcing the observation that the striatum is a dopaminergic region only on the 
basis of comparison to other brain regions. The low density of nicotinic acetylcholine 
receptors is interesting given that it is likely that every dopamine varicosity contains a 
nicotinic acetylcholine receptor. The data in figure 10 show the number of receptors 
divided by the number of varicosities containing the neurotransmitter that activates each 
receptor.  
Numbers of receptor subtypes provide useful and interesting information, but 
location of the receptors is crucial for understanding their functional roles. Various 
histochemical and electron microscopic techniques have been used to provide 
information on receptor protein location. Table 8 summarizes these data. Every 
dopaminergic and glutamatergic nerve terminal have been shown to express nicotinic 
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acetylcholine receptors (R. D. Schwartz, Lehmann, and Kellar 1984; Livingstone et al. 
2009).   Regarding muscarinic receptors, the M1 subtype is found on all medium spiny 
neurons. M2 receptors are found on glutamate terminals and on at least some cholinergic 
terminals, where they function to decrease release of glutamate and acetylcholine, 
respectively.  M4 receptors are located on approximately two thirds of medium spiny 
neurons (Alcantara et al. 2001; Liste, Bernard, and Bloch 2002; Lobo 2009; Harrison, 
Tissot, and Wiley 1996).   
One interesting item from this table is that dopamine D1 receptors are located 
only on MSN, and only on about 52% of them. A caveat associated with this observation 
is that receptors might be located elsewhere but at a level below detection limit. In spite 
of that caveat, it is clear that D1 receptors have a very restricted localization with regards 
to cell type. Another interesting item is that nicotinic acetylcholine receptors are found 
only on dopamine, glutamate, and serotonin axons/terminals and never on dendrites/cell 
bodies. In addition, AMPA receptors are located on glutamate and dopamine terminals as 
well as on dendrites. Ion-gating receptors on axons/terminals are most likely causing a 
depolarizing signal that participates in release of neurotransmitter. Thus, these ion-gating 
receptors provide a biochemical mechanism for amplifying the effects of an action 
potential when it reaches the terminal.  
Another technique for determining which cell type produces a receptor is mRNA 
expression. These data identify which cell types produce the mRNA necessary for a 
particular protein but do not determine the subcellular location of the receptors, such as 
dendrites, cell bodies, axons or terminals. These data do not necessarily identify a protein 
as being in the striatum. For example, if the receptors are expressed on the axons of 
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medium spiny neurons, they may not be located in the striatum and thus would not need 
to be included in this review. Nonetheless, we have collected all data we can and 
organized it into Table 9. Medium spiny neurons produce mRNA for a majority of the 
receptors found within the striatum based on the data we collected. The interneurons in 
the striatum, however, seem to only produce mRNA for a subset of the receptors, based 
on the literature we reviewed. For example, cholinergic interneurons have been found to 
produce mRNA for metabotropic glutamate receptors and GABAB receptors, but not D2 
receptors. GABAergic interneurons produce mRNA for GABAB receptor subunits and 
cannabinoid receptors. The combination of potential low abundance of mRNA coupled 
with the low abundance of interneurons likely produces the situation where some mRNA 
species may be missed. This would explain why the interneurons have been shown to 
express more receptor proteins (Table 8) than mRNA (Table 9).  
 
3.3.1. The Serotonergic System 
 
During our investigation, we uncovered interesting quantitative details relative to 
the serotonergic inputs to the striatum. The serotonergic inputs to the striatum account for 
less than 1% of the inputs present in the striatum. When we quantified the number of 
serotonin receptors, however, we found that there are over 2800 serotonin receptors for 
every input. This is the largest receptor to neurotransmitter input ratio we calculated, and 
suggests the serotonin input could have a powerful influence within the striatum. Because 
the number of inputs is low but the number of receptors is high, we hypothesize that, 
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instead of being evenly distributed, the serotonergic input is specific to one subtype of 
neuron.  
 
3.4. Dopamine Neighborhood 
 
As we are specifically interested in dopamine signaling in the striatum, we 
organized a set of quantitative details as they pertain to dopamine. Assuming dopamine 
signals in volume/neighborhood fashion, we asked the question of what other signaling 
elements are present in the neighborhood of a single varicosity based on statistical 
averages. Some dopamine receptors are located on axon terminals/varicosities, and the 
data presented earlier on varicosity density could be directly used to estimate type and 
number of varicosities likely containing presynaptic receptors. Other dopamine receptors 
are located on dendrites. We reason that in order for these to have an effective 
modulatory function, these receptors on dendrites are likely found in close apposition to 
varicosities. Thus, identification of varicosities/terminals in the vicinity of a single 
dopamine release site provides an estimate of the potential modulatory functions of 
dopamine D1 receptors. Figure 11 illustrates the varicosities/release sites found in the 
neighborhood of a single dopamine release site. 
Relative to D1 receptors, the vast majority, if not all, are located on elements of 
about 52% of MSN. MSN elements in the vicinity of a dopamine release site can include 
dendrites and axon terminals from the collateral axon tree. However, it is usually 
assumed that the bulk of the D1 receptors are on dendrites. Based on the data in Table 7, 
there are, on average, 220 dopamine D1 receptors within the neighborhood of a single 
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release site. We are not aware of any data suggesting whether these D1 receptors are 
randomly distributed along dendrites or specifically clustered in apposition to various 
varicosities/terminals. Activation of D1 receptors stimulates protein kinase A mediated 
protein phosphorylation. If D1 receptors are randomly distributed along the dendrites, 
then a substantial phosphorylation modification might occur that could markedly alter 
computational activity in the dendritic tree. On the other hand, if the D1 receptors are 
clustered in apposition to varicosities/terminals, then data from Figure 11 suggests that 
these receptors could be located where they might modulate post-synaptic inputs from 
about 5 glutamatergic, 2 GABAergic, and 2 cholinergic inputs where more than 20 D1 
receptors, on average, are available to modulate each input. If D1 receptors are clustered, 
it is possible that activated protein kinase A might be very intense in strategic locations. 
D2 receptors are located on about 48% of the MSNs, glutamate terminals, 
cholinergic interneurons and axons, as well as on dopaminergic varicosities. Based on the 
data in Table 7, there are, on average, 64 dopamine D2 receptors within the neighborhood 
of a single release site. It is estimated that about 20% of the D2 receptors are located on 
dopaminergic axons/varicosities and 70% are located on medium spiny neurons 
(Anzalone et al. 2012). This means, within the volume associated with one dopamine 
release site, 45 D2 receptors are located on medium spiny neurons, 13 D2 receptors on 
dopamine terminals, and 6 D2 receptors located on other elements. This small number of 
D2 receptors on MSN suggests either that receptors are strategically located where a 
localized signal could substantially modify current flow or that a substantial post-D2 
receptor amplification mechanism must exist in order for D2 receptor activation to 
modulate the computational activity of the MSN dendritic tree. It is not clear what this 
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might be since there is not a known enzyme stimulation associated with D2 receptors. 
Perhaps each activated receptor can in turn activate a substantial number of G-coupled 
proteins, which then can act on a substantial number of protein substrates. An alternate 
hypothesis is that the D2 receptors are preferentially located on the neuron where they 
would have maximum impact.  
In the case of D2 receptors on axon terminals, the small number, estimated at 13 
for dopamine terminals and 6 for other axon terminals, suggests a highly localized 
function within the small volume of these elements. Thus, receptor amplification is likely 
not needed. An estimate of number of dopamine transporter (made by dividing Bmax from 
binding studies by varicosity density) is about 2,500. It is not intuitively obvious why the 
number of proteins available to remove dopamine from signaling space is so much larger 
than the number of receptors. 
 
3.5. Caveats 
 
For all of the data we have used statistical averages and distributed everything 
equally, which may not actually be representative of the striatum. Likely, certain inputs 
preferentially innervate different neuron subtypes, and all receptors may not be evenly 
distributed across cells. For the purposes of this review, however, we wanted to be 
complete and to provide a general quantitative description of the striatum as a whole.  
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3.6. Conclusion 
 
In conclusion, our quantitative review has revealed that each neuron within the striatum 
receives over 12,500 individual inputs. This suggests that integration must occur within 
each cell, and it is likely that none of the inputs are privileged. The dopamine system in 
the striatum accounts for a minority of the elements, but the receptors are present on a 
majority of the cells and inputs, suggesting it has a broad influence on the overall 
function and output of the striatum. 
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Table 6: Quantitative details of axons present in striatum 
Neurotransmitter Cell Body Density # per Neuron 
Total All 10E+08 12,500 
a
 
Glutamatergic All 
All 
   Cortex 
   Sub cortex 
--- 
 
2.3E+08 
1.1E+08 
5,000 
b
 
4,300 
c
 
2,900 
d 
1,400 
d 
GABA All 1.9E+08 2,400 
e 
ACh Interneuron 2E+08 2,500 
f 
DA VTA/SN 1E+08 1,300 
g 
Serotonin Dorsal Raphe 3.2E+06 40 
h 
a
 density varicosities (Oorschot 1996)/ density of neurons (80,000 neurons/mm
3
 - see 
text) 
b
 spine density of 2.5 spines spines/μm (Shen et al. 2008) times a total dendrite length of 
about 2,000 µm (Meredith et al. 1992) 
c 
sum of averages of cortex and subcortex 
d
 average density of VGluT1 or VGluT2 (Wouterlood et al. 2012; Y. Zhang et al. 
2013)/density of neurons 
e
 average density of VGAT (Wouterlood et al. 2012)/ density of neurons 
f
 (Contant et al. 1996)/density of neurons 
g
 (Doucet, Descarries, and Garcia 1986)/ density of neurons 
h
 (Soghomonian, Doucet, and Descarries 1987; Soghomonian, Descarries, and Watkins 
1989)/density of neurons 
 
 
 
 
 
 
 
 
 
 
 65 
 
Figure 9: Visualization of inputs to a single medium spiny neuron. 
 (A) This illustration shows the massive number of inputs (only 1/10
th
 are actually 
shown) a single neuron receives in the striatum. Glutamatergic and GABAergic inputs 
are shown in this figure to directly synapse on dendritic branches of the neuron, while the 
modulatory neurotransmitters acetylcholine and dopamine have inputs scattered between 
the dendrites, as a majority of these inputs do not form direct synapses. (B) Magnification 
of a single dendrite segment identified by the box in (A). Each input type is labeled as 
shown in (C).  
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Table 7: Receptor density in the striatum. 
Receptor 
Average Bmax in 
fmol/mg total 
protein 
Cannabinoid 1075 
a
 
Nonselective muscarinic 1042 
b 
                 M1 427 
c 
                 M2 180 
d 
AMPA  838 
e
 
Nonselective dopaminergic 
                              
562 
f
   
                 D1 435 
g 
                 D2 127 
h 
Nonselective opioid 
                              
330 
i  
                Mu-opioid 120 
j 
               Delta-opioid 152 
k 
               Kappa-opioid 58 
l 
Serotonin  170 
 m 
Adenosine 157 
n 
Adrenergic 48 
o 
Nicotinic  19 
p 
a
 Derived from (Romero et al. 1995; Bidaut-Russell, Devane, and Howlett 1990) 
b
 Derived from (Gilbert, Hanley, and Iversen 1979; Nonaka and Moroji 1984) 
c
 Derived from (Watson, Yamamura, and Roeske 1983; Araujo, Lapchak, and Quirion 
1991; Lapchak et al. 1989b; Mendes de Freitas et al. 2005) 
d
 Derived from (Lapchak et al. 1989b) 
e
 Derived from (Kustova et al. 1997; Kürschner et al. 1998) 
f
 Sum of averages for D1 and D2 receptors 
g
 Derived from (Hyttel 1987; Mendes de Freitas et al. 2005) 
h
 Derived from (Murrin and Zeng 1986; Walters and Carr 1988; Hyttel 1987) 
i 
Sum of averages for mu, delta and kappa opioid receptors  
j
 Derived from (Bhargava, Gulati, and Ramarao 1989; Maher, Selley, and Childers 2000; 
Wewers et al. 1999; Fadda et al. 1992) 
k
 Derived from (Varona et al. 2003; Cadet and Rothman 1986; Vathy, Rimanóczy, and 
Slamberová 2000; Fadda et al. 1992) 
l
 Derived from (Tempel and Zukin 1987) 
m
 Derived from (Samanin et al. 1980; Mendes de Freitas et al. 2005; Hyttel 1987)
 
n 
Derived from (Halimi et al. 2000; Ferre et al. 1991; Cunha et al. 1996) 
o 
Derived from (Walters and Carr 1988) 
p 
Derived from (Lapchak et al. 1989a; Wigestrand et al. 2011; Speth et al. 1977) 
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Figure 10: Ratio of receptor density to inputs in the striatum. 
The data presented illustrates the ratio of density of receptors for each neurotransmitter 
system, calculated from Bmax data in Table 7, to the density of inputs calculated from 
Table 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Table 8: Receptor protein expression on striatal elements 
 Medium 
spiny 
neurons 
Cholinergic 
inter-neurons  
GABAergic 
inter-neurons 
Glutamate 
inputs 
Dopamine 
inputs 
Cholinergic 
axons 
GABAergic 
axons 
5-HT axons 
D1 receptor 
a          
D2 receptor 
b              
Muscarinic receptors 
c            
Nicotinic receptors 
d 
           
mGluRs 
e             
AMPA receptors 
f              
NMDA receptors 
g          
Kainate receptors 
h            
GABAA  receptors 
i
             
GABAB R1 subunit 
j
             
GABAB R2 subunit 
k
           
Adenosine receptors 
l           
Cannabinoid receptors 
m            
a 
(Strange 1993)  
b 
(Strange 1993; J. C. Schwartz et al. 1998; Tarazi and Baldessarini 1999) 
c
 (Alcantara et al. 2001; Liste, Bernard, and Bloch 2002; Lobo 2009; Harrison, Tissot, and    Wiley 1996) 
d
 (Livingstone et al. 2009; R. D. Schwartz, Lehmann, and Kellar 1984) 
e 
(Bonsi et al. 2007) 
f 
(Kwok et al. 1997; Stefani et al. 1998; Tarazi and Baldessarini 1999) 
g
 (Tarazi and Baldessarini 1999) 
h
 (Stefani et al. 1998; Tarazi and Baldessarini 1999) 
i 
 (Caruncho, Liste, and Labandeira-García 1996; Fritschy and Mohler 1995; Fujiyama et al. 2000; Härtig et al. 1995; Waldvogel et al. 1997) 
j 
(Lacey et al. 2005; Yung, Ng, and Wong 1999) 
k 
(Durkin et al. 1999; Ng and Yung 2001) 
l
 (Lobo 2009; Xie, Ramkumar, and Toth 2007) 
m
 (Cerovic et al. 2013; Oude Ophuis et al. 2014; Pisani et al. 2011) 
  
6
8
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Table 9: Receptor mRNA expression on striatal elements 
 Medium spiny 
neurons 
Cholinergic 
inter-neurons  
GABA-ergic inter-
neurons 
D1 receptor 
a     
D2 receptor 
b     
Muscarinic 
receptors 
c 
    
mGluRs 
d      
GABAA  receptors 
e
       
GABAB R1 subunit 
f
       
GABAB R2 subunit 
g
 
   
5-HT receptors 
h     
Adenosine receptors 
i 
    
Opioid receptors 
j     
Cannabinoid 
receptors 
k 
     
a 
(Strange 1993)  
b 
(Strange 1993; J. C. Schwartz et al. 1998; Tarazi and Baldessarini 1999) 
c
 (Alcantara et al. 2001; Liste, Bernard, and Bloch 2002; Lobo 2009; Harrison, Tissot, 
and    Wiley 1996) 
d 
(Bonsi et al. 2007) 
e 
 (Caruncho, Liste, and Labandeira-García 1996; Fritschy and Mohler 1995; Fujiyama et 
al. 2000; Härtig et al. 1995; Waldvogel et al. 1997) 
f 
(Lacey et al. 2005; Yung, Ng, and Wong 1999) 
g 
(Durkin et al. 1999; Ng and Yung 2001) 
h
 (Furay et al. 2011) 
i
 (Lobo 2009; Xie, Ramkumar, and Toth 2007) 
j
 (Oude Ophuis et al. 2014) 
k
 (Cerovic et al. 2013; Oude Ophuis et al. 2014; Pisani et al. 2011) 
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Figure 11: Varicosities and D2 receptors in the neighborhood of a single dopamine 
release site. 
For every one dopamine varicosity, there are 3 glutamate inputs from the cortex, 2 
glutamate inputs from the thalamus/amygdala, 2 cholinergic inputs and 2 GABA inputs. 8 
of the 10 inputs associated with one dopamine input express dopamine D2 receptors, as 
indicated by the dashed border around each input in the illustration.  
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Chapter 4: Computational Modeling of Dopamine Receptor Occupation in the 
Neighborhood of Single Dopamine Release Site 
 
4.1. Introduction 
 
 Dopamine signaling in the striatum and nucleus accumbens communicates 
novelty and saliency of the current environmental input and is involved in the learned 
formation of appropriate responses. Dopamine released in the extended striatum activates 
G-protein coupled receptors on multiple cells and axons in the area. The main two classes 
are dopamine D1 like receptors, which are coupled to a Gαs protein and stimulate 
adenylate cyclase, and D2 like receptors, which are coupled to a Gαi protein and inhibit 
cyclic AMP production, as well as modulate calcium and potassium channels (Beaulieu 
and Gainetdinov 2011). Dopamine D1 receptors are primarily expressed on 52% of the 
medium spiny neurons in the striatum (Cerovic et al. 2013). Dopamine D2 receptors are 
located on the other half of medium spiny neurons, as well as on cholinergic interneurons 
in the striatum. Dopamine D2 receptors are expressed on dopamine axons, glutamatergic 
axons, and cholinergic axons in the striatum and function as autoreceptors, as well.  
The number of dopaminergic cell bodies in VTA and SNc is small, about 20,000-
30,000 in mice and 40,000-45,000 in rats (Bjorklund and Dunnett, 2007); however, the 
axonal projections in the expanded striatum ramify extensively, forming dense, intricate 
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axonal arborizations (Gauthier et al., 1999; Matsuda et al., 2009; Prensa and Parent, 
2001). The axonal tree from one neuron can influence up to 5.7% of striatal volume 
(Matsuda et al., 2009). Dopaminergic axons have varicosities (dopamine release sites) 
distributed along their axons within the expanded striatum, making an estimated 500,000 
varicosities per neuron (Anden et al., 1966). Most (60-70%) of striatal dopaminergic 
varicosities are not associated with synaptic specialization (Descarries et al., 1996). This 
ultrastructural observation coupled with voltammetry experiments (Garris and Wightman, 
1994) suggest that dopamine signaling occurs through volume transmission. Thus, the 
neurotransmitter molecules can diffuse and affect receptors within a few micrometers of 
the release site. Recently, using a computer model, we showed that dopamine release 
probability in the rodent striatum is low. How this affects dopamine receptor occupancy, 
however, was not investigated. 
Multiple studies show that dopamine receptors are activated in the striatum and 
influence overall behavior. For example, du Hoffmann et al., recently showed that local 
blockade of either D1 or D2 receptors in rat nucleus accumbens inhibits the excitation of 
neurons in the striatum evoked by reward predictive cues during a sucrose reward task. 
Injection of the antagonists also increased the latency to reward seeking in the rodents 
(Hoffmann and Nicola 2014). Our group has determined the release rate of dopamine 
from a single varicosity was low using a computer model under both baseline conditions 
and after a large electrical stimulus (Chapter 2). This, paired with the information we 
have also gathered on the quantitative details of receptors in the striatum (Chapter 3), 
allowed us to create a model of receptor occupation within the volume associated with 
one dopamine release site in the rodent striatum.  
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The first goal of the current study is to estimate dopamine D1 and D2 receptor 
occupation under baseline conditions, utilizing either partial vesicle release or low release 
probability. This was done using both simple and complex computer simulation models 
of an extracellular compartment associated with a dopaminergic varicosity. These models 
were then used to evaluate the relationship between dopamine release rate and uptake, 
complexity of the simulation space, and receptor occupation. Receptor binding kinetics 
were pre-determined by matching the model output to published data on receptor binding 
affinities. Under baseline conditions, the results suggest that the low affinity D1 receptors 
remain unbound, while about 50% of the high affinity D2 receptors are bound to 
dopamine, on average. The second goal of this study was to evaluate D1 and D2 receptor 
occupation during simulations of a phasic burst. The results suggest that a short burst has 
very little effect on receptor occupation, suggesting the main purpose for the burst is not 
to increase receptor occupation. The third goal of the present study is to determine what 
the release probability needs to be in order to occupy a majority of the D1 receptors. Our 
model suggests this is dependent on the DAT kinetics and complexity of the model space.  
 
4.2. Materials and Methods 
 
4.2.1. Quantitative Parameters related to Dopamine Varicosities and Dopamine 
Receptors 
 
 The computer simulation model requires quantitative details describing dopamine 
varicosities, dopamine receptor details and DAT kinetics. A summary of gross tissue 
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level parameter values derived from published data is provided in Table 10. In the 
original publications, data are reported in a variety of different units (molar, pmol/mg 
protein, mg/gram wet weight, etc.). To facilitate comparisons, all data were converted to 
molar using conversion factors of 0.151 mg protein/mg tissue, 0.084 mg membrane 
protein/mg tissue, tissue density of 1 g/mL, and molar mass of dopamine of 153 g/mole. 
As reported previously (Chapter 2), values for DAT Vmax vary substantially between 
different experimental paradigms. For these models, we again elected to run our models 
using both values for the transporter Km. 
 Our computations and simulation models examined parameters associated with a 
single varicosity containing a single release site. Therefore, gross tissue values were 
converted to numbers associated with the average for a single varicosity (assumes that all 
sites are identical; Table 11). We determined the dopamine-DAT binding rate constants 
as described previously. To determine dopamine receptor binding rate constants, we used 
MCell simulations of dopamine binding assays in vitro. The association rate constant was 
varied to find a value that produced a Km value from simulation data equal to each of the 
average Km values we averaged from published data. The dissociation rate constant of 0.4 
per second was chosen based on the value used by Dreyer et al (Jakob Kisbye Dreyer and 
Hounsgaard 2013).  
 
4.2.2. Simple Simulation Model 
 
  Simulations of extracellular space associated with a dopaminergic varicosity 
were accomplished using MCell (Monte Carlo Cell), a stochastic simulation program that 
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uses Monte Carlo algorithms to estimate molecule movement and reactions in three-
dimensional space (J. R. Stiles et al. 1996; J. Stiles and Bartol 2001; Kerr et al. 2008). 
The model has five sets of parameters. One is a morphology representing extracellular 
space through which dopamine can diffuse. For these models we used a sphere with 
volume of 2.1x10
-15
 L (radius 0.79 μm) for the dorsal striatum. The second set of 
parameters characterized dopamine secretion into extracellular space. Dopamine was 
released from a point source on the surface of the model. The third set of parameters 
characterizes dopamine removal by DAT. The molecules were arranged in a band of 0.75 
microns width beginning 0.5 microns from the release site. In MCell, transport is 
modeled as a binding reaction followed by a transport step: 
DA + DAT  DADATDA_TRANS + DAT 
DADAT represents the bound DA·DAT complex.  The second reaction simulates 
dopamine transport with a recycling of the transporter (DADAT), where DA_TRANS 
represents transported dopamine. Forward rate constants for the first reaction were either 
5x10
6
 or 1.3x10
8
 per molar per second (see Table 11), reverse rate was 0.5 per second, 
and rate constant for the second reaction was 9 per second. The fourth set of parameters 
characterizes dopamine binding to the dopamine D1 receptors. The receptors were 
clustered on the surface of the model directly across from the release site and the binding 
was modeled as a single, reversible reaction:  
DA + D1  DAD1 
DAD1 represents the bound DA·D1 receptor complex. Forward rate constant was 5x10
5
 
M
-1
sec
-1 
and the reverse rate constant was 0.4 per second. The fifth set of parameters 
characterizes dopamine binding to the dopamine D2 receptors. The receptors were placed 
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in distinct clusters on surface of the model in three different areas to represent dopamine 
autoreceptors, D2 receptors on medium spiny neurons and D2 receptors on other 
varicosities. The binding was modeled as a single, reversible reaction: 
DA + D2DAD2 
DAD2 represents the bound DA·D2 receptor complex. Forward rate constant was 
8.2x10
7
 M
-1
sec
-1 
and the reverse rate constant was 0.4 per second.  
 
4.2.3. Complex Simulation Model 
 
 The striatum is a complex area filled with axonal fibers, blood vessels, neurons, 
and glial cells. This means a simple sphere is not the most accurate representation of the 
extracellular space in the striatum. To better simulate this space, we used MCell to also 
build a complex model of the space associated with one release site. This model consists 
of the same five parameters sets as described above for the simple simulation model, with 
additional parameters incorporated into the model space. The complex model consisted of 
an outer sphere with a volume of 1x10
-14
 L (radius of 1.36 μm). The space is filled with 6 
icospheres, each with a volume of 1.25x10
-15
 L (radius of 0.67 μm). Together, these 
icospheres add to a total of 7.5x10
-15
 L, leaving about 2.8x10
-15
 L of free space in the 
model, which we consider to be the extracellular space. The dopamine molecules are 
released from a point source in the center of the outer sphere. The transporters are 
surrounding this point source, and the dopamine D1 and D2 receptors are clustered to 
distinct areas across the icospheres (Figure 12). The dopamine D2 receptors that 
represent autoreceptors on the dopamine varicosities are approximately 0.2 μm from the 
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release site. Receptors that represent D2 receptors located on medium spiny neurons are 
located 0.45 μm to 1.35 μm from the release site, and D2 receptors located on other 
varicosities are approximately 1.36 μm from the release site. D1 receptors located on 
medium spiny neurons are located 0.45 μm to 1.35 μm from the release site as well.   
 
4.2.4. Modeling dopamine release 
 
 To model tonic dopamine release, we utilized two methods: constant partial 
vesicle release and intermittent full vesicle release. For simulations of baseline dopamine 
release using constant partial vesicle release, values for parameters were input into the 
model and a pre-determined portion of single dopamine vesicle was released every 0.2 
seconds (simulating 5 Hz firing rate). The simulation was run for sufficient iterations to 
produce a steady state level of extracellular dopamine. For simulations of an intermittent 
full vesicle release, the release rate was set to 5 Hz with a release probability of 1%. 
When a release event occurred, one full vesicle (1900 dopamine molecules) would be 
released.  
 To model a phasic burst of dopamine, we utilized the constant partial vesicle 
release method only. A pre-determined portion of single dopamine vesicle was released 
every 0.2 seconds (simulating 5 Hz firing rate) and then a random 3 pulse, 20 Hz firing 
event would occur sometime within the model. Each pulse of the phasic burst released 
the same pre-determined portion of the dopamine vesicle that is used for the 5 Hz 
baseline-firing events.  
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 To model an increase in release probability, the release rate was set to 5 Hz with a 
variable release probability. When a release event occurred, one full vesicle (1900 
dopamine molecules) would be released.  
 
4.3. Results 
 
4.3.1. Modeling receptor occupation with baseline dopamine release 
 
 Previously, we determined the release rate necessary to maintain an extracellular 
dopamine concentration in the dorsal striatum of 10 nM (Chapter 2). We expanded on 
these data to determine what percent of receptors are occupied and if morphological 
location of receptors influences the occupancy in a complex simulation model.  
The data in Tables 12 and 13 shows that, for both the slow and fast DAT kinetics, 
dopamine D1 receptor occupation is negligible while D2 receptor occupation varies 
between 7-67% depending on the parameters tested. In the constant partial vesicle release 
model the D2 receptor occupancy was much higher (45-63%) than in the intermittent full 
release (11-21%) model. In addition to a difference in average occupancy, there was a 
difference between the release models in the time course of occupancy. With constant 
partial vesicle release, there is a nearly constant level of D2 receptor occupancy. With the 
intermittent full release model, full occupancy occurred very briefly after a release event. 
However, dopamine release events were so sparse that the average occupancy was small 
(Figure 13). Finally, dopamine receptor occupancy did not differ substantially between 
the simple and complex model spaces.  
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4.3.2. Modeling receptor occupation in the presence of phasic dopamine burst firing 
 
Since dopamine neurons in the substantia nigra and ventral tegmental area are 
known to exhibit phasic firing events lasting up to 200 milliseconds when the subject is 
introduced to something novel (Heien and Wightman 2006), we modeled a single 3-pulse 
burst at 20 Hz on top of a tonic, 5 Hz firing rate. The model output showed a brief 
doubling of the extracellular dopamine content, but there was no change in dopamine D1 
or dopamine D2 receptor occupation (Figure 14).  
 
4.3.3. Modeling receptor occupation in the presence of an increased release probability 
  
Since D1 receptors must be occupied to produce D1 receptor mediated behaviors, 
we sought to determine the conditions in which significant receptor occupancy would 
occur. We did this by increasing the release probability for the intermittent full release 
model. The simulation suggests that, for fast DAT kinetic parameters, the release 
probability would need to be increased to 30% to activate about 80% of the dopamine D1 
receptors in the simple model. However, with slow DAT kinetics only around a 20% 
occupation of D1 receptors occurred with a 30% release probability (Tables 14 and 15).  
The simulations further showed that as release probability increases, dopamine 
D1 receptor occupation is dependent on the complexity of the simulation space. Thus 
receptors 0.79 μm from the release site show 77% occupancy while those at 1.35 μm 
show 25% occupancy. This suggests that the location of the D1 receptor determines its 
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signaling capability. We did not see this dependency at baseline levels of dopamine, but 
the extracellular dopamine concentrations at baseline are much lower than the Kd value of 
the D1 receptor (10 nM vs. 1 μM). This suggests that large bursts of dopamine release 
may preferentially activate the D1 receptors closest to the release site. The location 
dependency was not seen with the dopamine D2 receptors, but these receptors have a 
much higher affinity for dopamine (10 nM), and are almost fully saturated before 
substantial D1 receptor occupation occurs.  
 
4.4. Discussion 
 
The first goal of the current study is to estimate dopamine D1 and D2 receptor 
occupation under baseline conditions, utilizing either constant partial vesicle release or 
intermittent full vesicle release. Under baseline conditions, the results suggest that the 
low affinity D1 receptors remain unoccupied, while about 50% of the high affinity D2 
receptors are occupied, on average. The second goal of this study was to evaluate D1 and 
D2 receptor occupation during simulations of a phasic burst. The results suggest that a 
short burst has very little effect on receptor occupation, suggesting the main purpose for 
the burst is not to increase receptor occupation. The third goal of the present study is to 
determine what the release probability in the intermittent full release model needs to be in 
order to activate a majority of the D1 receptors. With higher release probability, D1 
receptor occupancy is markedly dependent on receptor location within the model and 
DAT kinetics. For example, a 30% release probability activates over 80% of D1 receptors 
in the simple model with fast DAT kinetics. The same release probability and DAT 
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kinetics only activates about 25% of the D1 receptors in the complex model. 
Furthermore, with slow DAT kinetics, only about 20% of D1 receptors were occupied in 
either model. This suggests that D1 receptor occupation is dependent on DAT kinetics 
and the complexity of the model space.  
 
4.4.1. Considerations relative to the simulation model 
 
 The model, in essence, consists of 4 components: dopamine release, DAT, 
dopamine receptors, and morphology. For this study, we utilized two different types of 
morphology, a simple sphere and a complex sphere. The ideal model would utilize an 
accurate morphology with the proper placement of all receptors and transporters relative 
to the release site. We have no data as to the exact location of receptors relative to a 
release site, but we do have data on components within the striatum that express these 
receptors. To best model the morphology in the striatum, we placed the receptors in 
distinct clusters throughout the model to represent the components on which they might 
be located.  
 In the simple model, we placed the receptors in clusters along the face of the 
sphere. Ultrastructural studies suggest the extracellular morphology is best approximated 
by a network of tubes with an average diameter of 35 nm (Thorne and Nicholson 2006). 
We have shown previously that our simple model is a valid model for a dopamine release 
site in the striatum because the dopamine diffusion rate is much faster than the rate of 
dopamine binding to DAT (Chapter 2).  
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 We also created a more complex modeling space to better represent the true 
morphology. In this model, we placed solid spheres within our model sphere to act as 
components within the striatum and create crevices and tunnels for the dopamine to 
diffuse through. The receptors were placed in clusters on distinct “components” to 
represent their placement throughout the striatum. There was no difference between the 
two models with a low dopamine release probability; however, as we increased the 
dopamine release probability, we found that morphology does have an impact on 
dopamine receptor occupation.  
 For dopamine receptor binding, we used binding data published in the literature 
and created models of receptor binding studies to determine the association and 
dissociation rates of binding. The binding rates we used, however, were determined from 
published studies in which the system was at equilibrium. The conditions we tested in 
this study did not necessarily create an environment in which the system was at 
equilibrium, which may have impacted our results. Our model is meant to simulate the 
average varicosity based on conditions and parameters that are already known, though, so 
constants determined from equilibrium binding are the most applicable parameters to use 
in this study.  
For dopamine D2 receptor binding, we found data for two different Kd values (10 
nM and 40 nM) as well as multiple studies on the existence of a short and long form of 
D2 receptors. There is also evidence that D2 receptors that function as autoreceptors are 
different from D2 receptors found on medium spiny neurons (Giros et al. 1989; Monsma 
et al. 1989; Usiello et al. 2000). These studies, however, do not point to any overall 
differences in receptor binding between the two different D2 receptor forms. We modeled 
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receptor binding for the two different Kd values and found little difference because the Kd 
values are very similar and both very close to baseline extracellular dopamine levels 
measured via no net flux microdialysis (10 nM) (Bianco et al. 2008; Castner, Xiao, and 
Becker 1993; Chen, Lai, and Pan 1997). We decided to use only the 10 nM Kd value for 
our modeling studies, which bias our results to higher levels of occupation. This gives us 
a maximum level of occupation for all parameters we tested.   
 To our knowledge, there is one other group that has published similar receptor 
occupation simulation results using their own computer model (Jakob K. Dreyer et al. 
2010). Using a mathematical model, Dreyer et al. obtained similar receptor occupation 
results to our MCell simulation output; however, their data on receptor occupation during 
phasic bursts differs. There are a few key differences between our two models, though. 
First, their simulation space was much larger than ours (15,000 μm3 vs. 2.1 μm3).  The 
larger simulation space included a maximum of 100 release sites, while our model 
contains only one release site. Both simulation models used the same Kd values for both 
D1 and D2 receptors. The biggest difference between both models is the dopamine 
release parameters. Dreyer et al. released dopamine tonically to obtain an average 
extracellular dopamine concentration of 37 nM. During phasic bursts, their extracellular 
dopamine concentration increased to 100-300 nM depending on the number of bursts. 
This is 3-fold higher than our baseline of 10 nM and more than 2-fold higher than our 
burst concentration. Given all these differences, however, Dreyer’s model still produced 
similar receptor occupation levels in their tonic model (3.5% D1 receptors bound, 75% 
D2 receptors bound) to our model (1% D1 receptors bound, 50% D2 receptors bound). 
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Both models reinforce the idea that dopamine D1 receptor occupation is low, and a large 
increase in extracellular dopamine is required to activate these receptors.  
 
4.4.2. Implications of the results 
 
Under baseline conditions, a little over half of the dopamine D2 receptors are 
occupied, on average, with a constant partial vesicle dopamine release mechanism. If this 
model is an accurate representation of the striatum, this implies significant D2 signaling 
under baseline conditions that could be either increased or decreased in response to 
changing levels of extracellular dopamine. The observations that D2 receptor antagonists 
increase extracellular dopamine levels and that D2 receptor agonists produce behavioral 
effects are consistent with this hypothesis (Beaulieu and Gainetdinov 2011). With the 
intermittent full vesicle release model, very short bursts of full D2 receptor occupancy 
occur infrequently with the result that average receptor occupancy is only about 10%. 
This implies a paradigm in which signaling is conveyed by frequency of pulses rather 
than average extracellular concentration.  
Less than 1% of the dopamine D1 receptors are occupied under baseline 
conditions within all DAT kinetic and morphological paradigms tested. This implies no 
D1 mediated signaling under baseline conditions.  
 Dopamine neurons are also known to fire in phasic bursts when the subject is 
introduced to a novel stimulus (Heien and Wightman 2006). We modeled a 3 pulse, 20 
Hz phasic burst randomly interspersed amongst tonic 5 Hz firing and found that the burst 
had no impact on overall receptor occupation. Our model shows a brief doubling of the 
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extracellular dopamine concentration but no increase in receptor occupation. Under the 
pulse conditions used, the increase in dopamine is so transient that the kinetics of 
receptor binding are not fast enough to register the concentration change. The small 
increase in extracellular dopamine we modeled agrees with multiple published studies. 
Floresco et al. used in vivo microdialysis to look at the DA concentration in rat nucleus 
accumbens. Stimulation of the pedunculopontine tegmental nucleus, a region that sends 
glutamatergic and cholinergic inputs to dopamine cell bodies in the VTA, did not produce 
any observable increase in extracellular dopamine. An increase in extracellular dopamine 
concentration was only observed after inhibition of DAT in the nucleus accumbens 
(Floresco et al. 2003). Another group used voltammetry to look at dopamine release in rat 
nucleus accumbens after exposure to a 50 kHz ultrasonic vocalization from rats, which 
they believe induces phasic dopamine firing. They saw a 5 nM increase in the 
extracellular dopamine transient via voltammetry after only this frequency, which 
matches our data (Willuhn et al. 2014). Another group looked at dopamine release via 
voltammetry in rats performing a lever press/sucrose reward paradigm and their data 
shows that the DA increases are only in the 5-10 nM range as well (Wassum, Ostlund, 
and Maidment 2012).  
It is possible that a burst occurs to prime the terminals with an influx of calcium 
from the rapid arrival of action potentials. This priming could then increase the release 
probability for the following release event. For the phasic bursts, we only released the 
same number of dopamine molecules in our model as we do for each action potential 
under tonic firing.  
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It is also possible that signals acting at the level of the terminal, such as activation 
of presynaptic nicotinic receptors, coupled with the phasic burst, increase the release rate 
enough to increase receptor occupation. Binding and functional data suggest that nearly 
every dopaminergic varicosity contains a nicotinic acetylcholine receptor (I. W. Jones, 
Bolam, and Wonnacott 2001). Activation of such receptors might further depolarize the 
membrane above the level induced by an action potential, allowing for dopamine release. 
Studies employing nicotinic agonists and antagonists have shown varying effects on 
dopamine release. However, a study using optogenetics to study the effect of cholinergic 
interneuron activation clearly documents that activation of a population of cholinergic 
interneurons elicits dopamine release in vivo in the absence of any other stimulus. This 
dopamine release was nicotinic receptor dependent and frequency independent (Threlfell 
et al. 2012). 
To model the hypothetical influence of nicotinic receptors, we used our model 
and increased the dopamine release probability until a majority of the dopamine D1 
receptors were occupied. To reach a >80% occupation of the D1 receptors in the simple 
model, we had to increase the release probability to 30%. When we increased the release 
probability in the complex model, however, we only saw about a 25% occupation of D1 
receptors. This was dependent on the DAT kinetics. These data suggests that location of 
the receptors and the complexity of the space has an impact on the probability of the 
receptors being activated. These results suggest that dopamine signaling is dependent on 
release probability, DAT kinetics, receptor location, and factors that increase release 
probability.  
  87 
Our model is meant to provide a global, average simulation of dopamine 
neurotransmission based on published data. The data and results provided here are not 
meant to provide exact numbers for all parameters involved, but rather provide evidence 
that support overall concepts. Based on our model, we hypothesize that local signals, 
such as presynaptic nicotinic receptors, act to increase dopamine release probability to 
enhance signaling within distinct neighborhoods. The striatum receives thousands of 
inputs as discussed in chapter 3, and local signals acting at the dopamine terminal would 
allow for the signaling of specific behaviors that do not require large, global increases in 
dopamine. This would allow for distinct signaling through the various regions of the 
striatum and lead to different outputs depending on the signal.  
In conclusion, under baseline dopamine release conditions, only about half of the 
dopamine D2 receptors within the sphere of a single release site are activated. This does 
not change after a phasic burst. The only way to activate D1 receptors is to increase the 
dopamine release probability to 30% or higher. Signals that act at the terminal, such as 
nicotinic receptors, may have the capability of increasing dopamine release probability to 
levels that activate D1 receptors. The D1 receptor occupation is dependent on the location 
of the receptors with regards to the release site as well as the DAT kinetics. This suggests 
that multiple factors are vital to dopamine signaling.   
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Table 10: Parameter values derived from biochemical data for rodent dorsal striatum 
Parameter Value 
Dopamine level  79.2 μM a 
Dopamine varicosity density  1x10
+8
/mm
3 b
 
Dopamine transporter level  0.47 μM c 
Dopamine transporter Vmax  4.08 μM/sec 
d
 
Dopamine transporter Km (transfected cells) 2.17 μM 
e
 
Dopamine transporter Km (tissue prep) 0.2 μM 
f
 
Dopamine D1 receptor level 0.01 μM g 
Dopamine D1 receptor Kd 1 μM 
h 
Dopamine D2 receptor level 0.04 μM i 
Dopamine D2 receptor Kd 10 nM 
j 
a
 Derived from (Abekawa et al., 2001; Bardullas et al., 2011; Buu, 1989; Cartmell et al., 
2000; Gao and Dluzen, 2001; Miller et al., 1980; Ponzio et al., 1984; Sharp et al., 1986; 
Takahashi et al., 1997; Vezina et al., 1992; Yu et al., 2001; Yuan et al., 2001) 
b
 Derived from (Doucet et al., 1986)  
c
 Derived from (Boja et al., 1995; Bonnet et al., 1986; Chen et al., 1997a; Dubocovich 
and Zahniser, 1985; Erikson et al., 2000; Garreau et al., 1997; Hooks et al., 1994; 
Janowsky et al., 1986; Marshall et al., 1990; Moll et al., 2000; Nakayama et al., 1993; 
Rothman et al., 1994) 
d
 Derived from (Garris and Wightman, 1994; May and Wightman, 1989; Wu et al., 2001) 
e
 Derived from (Carneiro et al., 2002; Chang et al., 2001; Eshleman et al., 1995; Itokawa 
et al., 2000; Kitayama et al., 1992; Lee et al., 1996; Lin and Uhl, 2002; Lin and Uhl, 
2005; Loland et al., 1999; Loland et al., 2002; Melikian and Buckley, 1999; Norregaard 
et al., 1998; Norregaard et al., 2000; Yatin et al., 2002) 
f 
Derived from (Harris and Baldessarinig, 1973; Horn, 1990; Marshall et al., 1990; Near 
et al., 1988; Rothman et al., 2001; Snyder and Coyle, 1969; Wu et al., 2001) 
g
 (Hyttel 1987; Mendes de Freitas et al. 2005) 
h
 (Jakob Kisbye Dreyer and Hounsgaard 2013; Rice and Cragg 2008) 
i 
(Hyttel 1987; Murrin and Zeng 1986; Walters and Carr 1988) 
j
 (Jakob Kisbye Dreyer and Hounsgaard 2013; Rice and Cragg 2008) 
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Table 11: Parameter values associated with a single varicosity. 
Parameter Value 
Number of dopamine molecules per varicosity 475,000 
Number of vesicles per varicosity 250 
Number of dopamine molecules per vesicle 1,900 
Extracellular volume surrounding a release site (dorsal striatum) 2x10
-15
 liter 
Number of DAT associated with a release site 2,800 
DAT catalytic rate 9 /sec 
DAT-DA binding on-rate (transfected cells) 
DAT-DA binding on-rate (tissue prep) 
5x10
+6
 M
-1
sec
-1 
1.3x10
+8
 M
-1
sec
-1
 
DAT-DA binding off-rate 0.5 sec
-1
 
D1-DA binding on-rate 5x10
5
 M
-1
sec
-1
 
D1-DA binding off-rate 0.4 sec
-1
 
D1 receptor number 220 
D2-DA binding on-rate 8.2x10
7
 M
-1
sec
-1
 
D2-DA binding off-rate 0.4 sec
-1
 
D2 receptors located on medium spiny neurons 45 
b 
D2 receptors located on dopamine terminals 13 
b 
D2 receptors located on other varicosities 6 
b 
Dopamine diffusion rate 4x10
-6
 cm
2
/sec 
a
 
a
 Derived from (Land et al., 1984; Rice and Cragg, 2008; Schonfuss et al., 2001) 
b 
D2 receptor distribution derived from (Anzalone et al. 2012) 
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Figure 12: Complex model simulation space. 
Dopamine is released from the center sphere. Six icospheres (2 not pictured) act to 
provide barriers to the free diffusion of dopamine as well as provide a surface for 
dopamine D1 and D2 receptors to reside.  
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Table 12: Estimated rate of basal dopamine release at 5 Hz in dorsal striatum 
simulation models
1
. 
Model Concentration
1
 
Release 
Rate
2
 
% D1 
occupied 
% D2 on 
MSN 
occupied 
% D2 on 
DA 
terminals 
occupied 
% D2 on 
other 
terminals 
occupied 
Simple- 
Constant 
partial 
vesicle 
release 
8 nM 20 0.6 54.2 63.1 46.7 
Complex- 
Constant 
partial 
vesicle 
release 
9 nM 20 0.7 45.1 44.8 66.7 
Simple- 
intermittent 
full vesicle 
release 
12 nM 1900 1.3 20.4 20.8 16.7 
Complex- 
intermittent 
full vesicle 
release 
7 nM 1900 0.5 11.9 11.5 15 
1
 Simulations used a simple or complex morphology, 5 Hz firing rate, 2,800 total 
DAT molecules with a transport rate of 9 dopamine per second and an on-rate of 
dopamine binding to DAT of 5x10
6 
M
-1
 sec
-1
. Intermittent full vesicle release 
models had a release probability of 1%. 
2
average dopamine concentration from the simulation output  
3
release rate is number of dopamine molecules released per firing event to 
produce the average extracellular dopamine concentration listed. 
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Table 13: Estimated rate of basal dopamine release at 5 Hz in dorsal striatum 
simulation models
1
. 
Model Concentration
1
 
Release 
Rate
2
 
% D1 
occupied 
% D2 on 
MSN 
occupied 
% D2 on 
DA 
terminals 
occupied 
% D2 on 
other 
terminals 
occupied 
Simple- 
Constant 
partial 
vesicle 
release 
9 nM 50 0.7 56.9 59.2 60.0 
Complex- 
Constant 
partial 
vesicle 
release 
10 nM 50 0.8 44.0 56.2 45.0 
Simple- 
intermittent 
full vesicle 
release 
14 nM 1900 1.4 12.2 15.4 18.3 
Complex- 
intermittent 
full vesicle 
release 
12 nM 1900 0.5 6.9 10.0 8.3 
1
 Simulations used a simple or complex morphology, 300 total DAT molecules 
with a transport rate of 9 dopamine per second and an on-rate of dopamine 
binding to DAT of 1.3x10
8
 M
-1
 sec
-1
. Intermittent full vesicle release models had 
a release probability of 1%. 
2
average dopamine concentration from the simulation output  
3
release rate is number of dopamine molecules released per firing event to 
produce the average extracellular dopamine concentration listed. 
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Figure 13: Dopamine D2 receptor occupation with a constant partial vesicle release 
model versus an intermittent full vesicle release model. 
 
Simulation of dopamine D2 receptor occupation using the simple model and fast DAT 
kinetics. Red line indicates D2 receptor occupation when one dopamine vesicle (1900 
molecules) is released using an intermittent full vesicle release model with a 1% release 
probability across 30 seconds of simulated data. Black dots represent D2 receptor 
occupation under a constant partial vesicle release simulation of 50 dopamine molecules 
per pulse at a 5 Hz firing rate for 30 seconds of simulated data. DAT kinetics were as 
follows: 300 dopamine transporters, Vmax=9 dopamine/second, Kon rate for dopamine 
binding to DAT= 1.3x10
8
 M
-1
 sec
-1
.  
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Figure 14: Dopamine receptor occupation compared to extracellular dopamine content 
after a 3 pulse phasic burst. 
The number of extracellular dopamine molecules are indicated by the open circle. No 
observable increase in D1 (gray circle) or D2 (open diamond) receptor occupation is 
seen. For this simulation the simple model and fast DAT kinetics were used. Simulation 
consisted of a tonic, 5 Hz firing rate using constant partial vesicle release of 50 dopamine 
molecules per pulse with one 3 pulse, 20 Hz phasic burst occurring at 3 seconds. DAT 
kinetics were as follows: 300 dopamine transporters, Vmax=9 dopamine/second, Kon rate 
for dopamine binding to DAT= 1.3x10
8
 M
-1
 sec
-1
.  
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Table 14: Estimated extent of receptor occupation with a 30% release probability-slow 
DAT
1
. 
Model Concentration
1
 
Release 
Rate
2
 
% D1 
occupied 
% D2 on 
MSN 
occupied 
% D2 on 
DA 
terminals 
occupied 
% D2 on 
other 
terminals 
occupied 
Simple 0.25 μM 1900 21.6 85.6 84.6 83.3 
Complex 0.5 μM 1900 22.1 80.0 92.3 78.3 
1
 Simulations used a simple or complex morphology, 5 Hz firing rate, 2,800 total 
DAT molecules with a transport rate of 9 dopamine per second and an on-rate of 
dopamine binding to DAT of 5x10
6 
M
-1
 sec
-1
. 
1
average dopamine concentration from the simulation output  
2
release rate is number of dopamine molecules released per firing event to 
produce the average extracellular dopamine concentration listed. 
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Table 15: Estimated rate of receptor occupation with a 30% release probability-fast 
DAT
1
. 
Model Concentration
1
 
Release 
Rate
2
 
% D1 
occupied 
% D2 on 
MSN 
occupied 
% D2 on 
DA 
terminals 
occupied 
% D2 on 
other 
terminals 
occupied 
Simple 6.6 μM 1900 77.2 95.6 94.6 95.0 
Complex 1.0 μM 1900 24.8 73.3 88.5 68.3 
1
 Simulations used a simple or complex morphology, 300 total DAT molecules 
with a transport rate of 9 dopamine per second and an on-rate of dopamine 
binding to DAT of 1.3x10
8
 M
-1
 sec
-1
. 
1
average dopamine concentration from the simulation output  
2
release rate is number of dopamine molecules released per firing event to 
produce the average extracellular dopamine concentration listed. 
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Chapter 5: Computational Modeling of Dopamine Receptor Occupation in the 
Neighborhood of Single Dopamine Release Site in the Presence of Cocaine and 
Amphetamine 
 
5.1. Introduction 
 
The dopamine neurons of the ventral tegmental area are one component of the 
reward pathway in the brain, which reinforces behavior that is necessary for survival such 
as eating, drinking and sex.  When an unanticipated reward is presented, dopamine 
signaling increases.  This increase modulates circuits involved in memory and behavior, 
which ensures that these behaviors are repeated.  Addicting drugs hijack this pathway and 
increase the extracellular levels of dopamine by increasing firing rate, increasing the 
amount of dopamine released or through non-exocytotic mechanisms.  Whenever the 
addicting drug is present, it causes an increase in extracellular dopamine, which 
reinforces use of the drug (Hyman, Malenka, and Nestler 2006).  Long-term use causes a 
change in the circuits of the brain, which eventually causes the user to become dependent 
on the drug. 
Amphetamine and cocaine are both powerful stimulants that have addicting 
properties. In most studies it is believed that the drugs’ ability to increase extracellular 
dopamine in the extended striatum is required for the hyperactivity and rewarding 
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properties of these chemicals (Bozarth and Wise 1986; Koob and Bloom 1988; Kuhar, 
Ritz, and Boja 1991). Although both of these drugs increase extracellular dopamine, they 
do so in different ways. Cocaine blocks the reuptake of dopamine, leading to an 
accumulation of the neurotransmitter in the extracellular space, whereas amphetamine 
produces its effects by promoting release of dopamine from non-vesicular pools as well 
as by blocking reuptake of the neurotransmitter (Fischer and Cho 1979). The difference 
in mechanism leads to a much larger increase in extracellular dopamine by amphetamine 
as compared to by cocaine.  
This difference in amount of increase in extracellular dopamine may have 
mechanistic relevance in that some effects of cocaine are not attenuated by dopamine 
receptor blockers while all effects of amphetamine are. For example, in the presence of 
dopamine receptor antagonists, cocaine-induced hyper-locomotion is reduced, whereas 
conditioned place preference is unaffected (Kaddis, Uretsky, and Wallace 1995; Spyraki, 
Fibiger, and Phillips 1982a). Unlike cocaine, the presence of dopamine receptor 
antagonists reduce both amphetamine induced hyper-locomotion as well as place 
preference (Mackey and van der Kooy 1985; McGregor and Roberts 1993; Spyraki, 
Fibiger, and Phillips 1982b). This suggests that dopamine receptor occupation may be 
differentially affected between the two psychostimulants.   
The goal of this study is to determine how the increase in extracellular dopamine 
in the presence of cocaine or amphetamine alters dopamine receptor occupation. This was 
done using computer simulation models of an extracellular compartment associated with 
a dopaminergic varicosity. These models were then used to evaluate the relationship 
between dopamine release rate, uptake and receptor binding, all in the presence of 
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increasing concentrations of cocaine or 2 mg/kg amphetamine. Simulation results suggest 
that the highest cocaine dose tested increases dopamine D2 receptor occupation by about 
30%, whereas it only increases dopamine D1 receptor occupation by about 4%.  2 mg/kg 
amphetamine increases dopamine D1 receptor occupation to 13% in the simple model, 
but only to about 6% in the complex model. D2 receptors are almost fully saturated 
(~97%) in the presence of 2 mg/kg amphetamine in the simple model, but only about 
70% are bound in the complex model. The conclusion of our paper is that micromolar 
concentrations of cocaine in the striatum significantly increase dopamine D2 receptor 
occupation, but have a lesser effect on D1 receptor occupation. The presence of 2 mg/kg 
amphetamine causes a larger increase in extracellular dopamine than cocaine, which 
leads to a higher percentage of D1 receptors bound.  
 
5.2. Materials and Methods 
 
5.2.1. Quantitative parameters related to dopamine varicosities and dopamine receptors 
 
 The computer simulation model requires quantitative details describing dopamine 
varicosities, dopamine receptor details and DAT kinetics. A summary of gross tissue 
level parameter values derived from published data is provided in Table 16. In the 
original publications, data are reported in a variety of different units (molar, pmol/mg 
protein, mg/gram wet weight, etc.). To facilitate comparisons, all data were converted to 
molar using conversion factors of 0.151 mg protein/mg tissue, 0.084 mg membrane 
protein/mg tissue, tissue density of 1 g/mL, and molar mass of dopamine of 153 g/mole. 
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As reported previously, (Chapter 2) values for DAT Vmax vary substantially between 
different experimental paradigms. For these models, we elected to run our models using 
only the fast DAT kinetics. 
 Our computations and simulation models examined parameters associated with a 
single varicosity containing a single release site. Therefore, gross tissue values were 
converted to numbers associated with the average for a single varicosity (assumes that all 
sites are identical) (Table 17). We determined the dopamine-DAT binding rate constants 
as described previously. Briefly, to determine the constants we used MCell simulations of 
dopamine binding assays in vitro. The association rate constant was varied to find a value 
that produced a Km value from simulation data equal to each of the average Km values we 
averaged from published data. The dissociation rate constant of 0.4 per second was 
chosen based on the value used by Dreyer et al (Jakob Kisbye Dreyer and Hounsgaard 
2013).  
 
5.2.2. Simple simulation model 
 
Simulations of extracellular space associated with a dopaminergic varicosity were 
accomplished using MCell (Monte Carlo Cell), a stochastic simulation program that uses 
Monte Carlo algorithms to estimate molecule movement and reactions in three-
dimensional space (J. R. Stiles et al. 1996; J. Stiles and Bartol 2001; Kerr et al. 2008). 
The model has five sets of parameters. One is a morphology representing extracellular 
space through which dopamine can diffuse. For these models we used a sphere with 
volume of 2.1x10
-15
 L (radius 0.79 μm) for the dorsal striatum. The second set of 
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parameters characterized dopamine secretion into extracellular space. Dopamine was 
released from a point source on the surface of the model. The third set of parameters 
characterizes dopamine removal by DAT. The molecules were arranged in a band of 0.75 
microns width beginning 0.5 microns from the release site. In MCell, transport is 
modeled as a binding reaction followed by a transport step: 
DA + DAT  DADATDA_TRANS + DAT 
DADAT represents the bound DA·DAT complex.  The second reaction simulates 
dopamine transport with a recycling of the transporter (DADAT), where DA_TRANS 
represents transported dopamine. The forward rate constant for the first reaction was 
1.3x10
8
 per molar per second (see Table 17), reverse rate was 0.5 per second, and rate 
constant for the second reaction was 9 per second. The fourth set of parameters 
characterizes dopamine binding to the dopamine D1 receptors. The receptors were 
clustered on the surface of the model directly across from the release site and the binding 
was modeled as a single, reversible reaction:  
DA + D1  DAD1 
DAD1 represents the bound DA·D1 receptor complex. Forward rate constant was 5x10
5
 
M
-1
sec
-1 
and the reverse rate constant was 0.4 per second. The fifth set of parameters 
characterizes dopamine binding to the dopamine D2 receptors. The receptors were placed 
in distinct clusters on surface of the model in three different areas to represent dopamine 
autoreceptors, D2 receptors on medium spiny neurons and D2 receptors on other 
varicosities. The binding was modeled as a single, reversible reaction: 
DA + D2DAD2 
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DAD2 represents the bound DA·D2 receptor complex. Forward rate constant was 
8.2x10
7
 M
-1
sec
-1 
and the reverse rate constant was 0.4 per second.  
For the purposes of this model, we released dopamine at a rate of 5 Hz with 
partial vesicle release for each firing event. Using published data, we determined the 
brain concentration of cocaine for increasing i.p. injections of cocaine (5-25 mg/kg) by 
utilizing the best fit line in Figure 16. Release conditions for amphetamine were 
determined previously by our lab to match published data on brain dopamine and 
amphetamine concentrations after administration of 2 mg/kg amphetamine in rodents.  
 
5.2.3. Complex Simulation Model 
 
 The striatum is a complex area filled with axonal fibers, blood vessels, neurons, 
and glial cells. This means a simple sphere is not the most accurate representation of the 
extracellular space in the striatum. To better simulate this space, we used MCell to also 
build a complex model of the space associated with one release site. This model consists 
of the same five parameters sets as described above for the simple simulation model, with 
additional parameters incorporated into the model space. The complex model consisted of 
an outer sphere with a volume of 1x10
-14
 L (radius of 1.36 μm). The space is filled with 6 
icospheres, each with a volume of 1.25x10
-15
 L (radius of 0.67 μm). Together, these 
icospheres add to a total of 7.5x10
-15
 L, leaving about 2.8x10
-15
 L of free space in the 
model, which we consider to be the extracellular space. The dopamine molecules are 
released from a point source in the center of the outer sphere. The transporters are 
surrounding this point source, and the dopamine D1 and D2 receptors are clustered to 
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distinct areas across the icospheres (Figure 12). The dopamine D2 receptors that 
represent autoreceptors on the dopamine varicosities are approximately 0.2 μm from the 
release site. Receptors that represent D2 receptors located on medium spiny neurons are 
located 0.45 μm to 1.35 μm from the release site, and D2 receptors located on other 
varicosities are approximately 1.36 μm from the release site. D1 receptors located on 
medium spiny neurons are located 0.45 μm to 1.35 μm from the release site as well.   
 
5.2.4. Cocaine model parameters 
 
 In order to model the effect of cocaine on the extracellular concentration of 
dopamine, we first had to determine the correct kinetic parameters for cocaine binding to 
DAT. In order to do this, we modeled an in vitro receptor-binding assay. The association 
and dissociation rate constants were varied to find a set of values that produced a Km 
value from simulation data equal to each of the average Km values we averaged from 
published data. In MCell, we modeled cocaine binding to DAT as a binding reaction: 
COC + DAT  COCDAT 
COCDAT represents the bound cocaineDAT complex. This reversible binding equation 
has a forward rate constant of 1.3x10
6
 M
-1
 sec
-1
 and a reverse rate of 3 per second.  
 
5.2.5. Amphetamine model parameters 
 
Previously our lab has determined the ideal parameters to best model the increase 
in extracellular dopamine in the presence of amphetamine. To best model the effects of 
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amphetamine, we had to alter our dopamine release parameters as well as use transporter 
kinetics similar to the slow DAT kinetics we determined previously. Dopamine was 
released at 5 Hz, with each action potential releasing 21 dopamine molecules into the 
extracellular space with an initial release of 240 dopamine molecules to achieve steady 
state in the model within the 10-second model timespan. In MCell, we modeled 
amphetamine binding to DAT as a binding reaction: 
AMPH + DAT  AMPHDAT 
AMPHDAT represents the bound amphetamineDAT complex. This reversible binding 
equation has a forward rate constant of 2x10
6
 M
-1
 sec
-1
 and a reverse rate of 0.5 per 
second. 16800 amphetamine molecules were released into the extracellular space at the 
start of the simulation to represent 2 mg/kg amphetamine. A non-DAT removal 
mechanism was also included in this model to account for all other dopamine removal 
processes such as diffusion or uptake into glial cells. All parameters used for the 
amphetamine model are listed in Table 18.  
 
5.3. Results 
 
5.3.1. Modeling striatal extracellular dopamine in presence of increasing doses of 
cocaine 
 
 We first used published data to confirm the accuracy of our model. Data from 
multiple sources that measured the striatal extracellular dopamine concentration in 
response to cocaine administration was pooled and graphed. As the cocaine concentration 
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increases, there is a linear increase in extracellular dopamine concentration (Figure 15). 
We also pooled published data on the measured brain concentration of cocaine for 
multiple doses of cocaine. This also showed a linear relationship with the dose of cocaine 
administered (Figure 16). In our computer simulation, we used a best-fit line to determine 
the cocaine concentration in the brain for a given dose (Table 19) and then determined 
the extracellular dopamine concentration. Our model values are shown with the published 
data in Figure 15.  
 
5.3.2. Modeling dopamine receptor occupancy in presence of increasing doses of cocaine 
 
 Cocaine binds to the dopamine transporter, leading to an increase in extracellular 
dopamine. This study was done to determine how the cocaine-induced increase in 
extracellular dopamine alters dopamine receptor occupancy. We found that the presence 
of increasing concentrations of cocaine increases dopamine D2 receptor occupancy from 
a control of about 50% to near full occupancy (Figure 17). We also found that for all 
doses tested, cocaine only slightly increases dopamine D1 receptor occupancy, going 
from approximately 1% occupation in controls to a maximum of about 5% of receptors 
occupied at the highest concentration of cocaine (25 mg/kg, Figure 18). We achieved 
similar occupancy results for the 5 and 10 mg/kg doses in the complex model (1.5% D1 
bound, 50-70% D2 bound).  
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5.3.3. Modeling dopamine receptor occupancy in presence of 2 mg/kg amphetamine 
 
 Amphetamine also affects the dopamine transporter and causes an increase in 
extracellular dopamine. Published studies suggest amphetamine causes a much larger 
increase in extracellular dopamine than cocaine (De Souza Silva et al. 1997). We sought 
to model how this larger increase in extracellular dopamine influences receptor 
occupation. We used both the simple and complex model to study the impact of 2 mg/kg 
amphetamine on dopamine receptor occupation. We found that, in the simple model, 2 
mg/kg amphetamine increased dopamine D1 receptor occupation to 13% and D2 receptor 
occupation to about 97%. When we ran the same parameters in the complex model, 
however, our average extracellular dopamine concentration was lower (0.1 μM vs. 0.22 
μM). The lower extracellular dopamine concentration resulted in lower levels of 
dopamine receptor occupancy (Figure 19).  
 
5.4. Discussion 
 
Cocaine and amphetamine are both addicting drugs that increase the extracellular 
concentration of dopamine in the striatum by interacting with the dopamine transporter. 
The goal of this study is to determine how the increase in extracellular dopamine in the 
presence of the drugs alters dopamine receptor occupation. This was done using a simple 
computer simulation model of an extracellular compartment associated with a 
dopaminergic varicosity. Simulation results suggest that the highest cocaine dose tested 
increases dopamine D2 receptor occupation by about 30% from a baseline of about 50%, 
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whereas it only increases dopamine D1 receptor occupation to 4%.  2 mg/kg 
amphetamine increases dopamine D1 receptor occupation to 13% in the simple model, 
but only to about 6% in the complex model. D2 receptors are almost fully saturated 
(~97%) in the presence of 2 mg/kg amphetamine in the simple model, but only about 
70% are bound in the complex model. The conclusion of our paper is that micromolar 
concentrations of cocaine and amphetamine in the striatum significantly increase 
dopamine D2 receptor occupation, but have a lesser effect on D1 receptor occupation.  
 
5.4.1. Considerations relative to the simulation model 
 
 The model, in essence, consists of six components: dopamine release, DAT, D1 
receptor binding, D2 receptor binding, drug binding and morphology. Of these, the 
parameter that deviates most from reality is morphology. A simple sphere does not 
accurately represent the extracellular space in the striatum, as it is simpler than the 
network of tubes thought to create the extracellular space (Thorne and Nicholson 2006). 
Therefore, we also used a complex simulation space to determine receptor occupation in 
the presence of 5 and 10 mg/kg cocaine as well as 2 mg/kg amphetamine. The 
conclusions are the same for both models even though the details are slightly different. 
Receptor occupation was lower overall in the complex model compared to the simple 
model. We believe the results achieved with our simple model are suggestive of the 
maximum receptor occupation in the presence of increasing concentrations of cocaine, 
which provides support of our conclusion that cocaine does not greatly increase 
dopamine D1 receptor occupation, whereas amphetamine has a slightly larger effect.  
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For DAT kinetics, different parameter values were used in the cocaine and 
amphetamine simulations. For the cocaine simulation, the fast rate of onset for DAT was 
used because this parameter achieves similar increases in extracellular dopamine in the 
presence of cocaine to the published data. No combination of kinetic parameters could be 
found to achieve similar results with the slow DAT kinetic parameters used in previous 
studies. In contrast to cocaine, amphetamine has effects other than inhibition of dopamine 
transporter. These additional effects alter rate of dopamine secretion. A separate project 
determined a set of parameters for which the simulation output matches published data. 
This set of parameters involved the slow DAT kinetics. The important factor relative to 
receptor occupation is level of extracellular dopamine. Thus, it appears that resolution of 
the problem of which set of DAT kinetics apply in the brain will have no effect on the 
conclusions relative to receptor occupancy.  
 
5.4.2. Implication of results 
 
 Regarding D2 receptors, the simulations suggest that, even under low probability 
release conditions, increases in extracellular dopamine elicited by cocaine or 
amphetamine are sufficient to occupy all D2 receptors. In contrast, D1 receptors remain 
largely unoccupied. However, we know they must become occupied because behavioral 
studies show that the presence of dopamine antagonists in the nucleus accumbens reduce 
cocaine-induced locomotion (Maldonado et al. 1993; McGregor and Roberts 1993; 
Kaddis, Uretsky, and Wallace 1995), as well as the locomotor and place preference 
effects of amphetamine (Mackey and van der Kooy 1985; Mithani et al. 1986; Spyraki, 
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Fibiger, and Phillips 1982b). These data suggest that D1 receptors are activated in the 
presence of stimulants. We hypothesize that local signals acting at the terminal that have 
the ability to increase dopamine release probability, coupled with the effects 
psychostimulants have on extracellular dopamine concentration, work synergistically to 
increase dopamine D1 receptor binding. In the presence of these drugs, low-powered 
local signals that increase dopamine release are enhanced and may activate D1 receptor 
pathways that normally would not be activated in the absence of the drug. Another 
possibility is that signals acting at the level of the D1 receptor have the capability to 
move D1 receptors into a high affinity state, which would then increase D1 receptor 
activation. It is not clear if factors that can influence the interaction between the G-
protein and receptor exist, or if receptors are able to switch between high and low affinity 
states easily. However, assuming signals exist that can change the affinity state of 
dopamine D1 receptors, these signals would be able to alter dopamine D1 receptor 
activation. Either of these conditions could have the potential to increase dopamine D1 
receptor binding to a level that would explain the behavioral effects of dopamine receptor 
antagonists in the presence of cocaine and amphetamine.  
 Cocaine may also be exerting its behavioral effects through non-dopaminergic 
receptors as well. Recently, experiments have shown that cocaine also targets the sigma-1 
receptor. This receptor is expressed in the brain and in various peripheral tissues.  The 
exact function of the sigma-1 receptor remains to be elucidated, but it has been shown to 
modulate the function of dopamine, acetylcholine, NMDA and opioid receptors 
(Narayanan et al. 2011).  The natural ligand for the sigma-1 receptors has yet to be 
elucidated as well, but some believe neurosteroids are able to bind this receptor (Cobos et 
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al. 2008). Sigma receptor antagonists and sigma-1 receptor knockdown reduces cocaine-
induced locomotor hyperactivity and blocks induction and expression of cocaine-induced 
conditioned place preference in rodents (Robson et al. 2012). Other evidence also 
suggests that the glutamate plays a role in the addicting properties of psychostimulants. 
When the AMPA receptor antagonist DNQX is administered prior to cocaine 
administration, it attenuates the acquisition of conditioned place preference (Kaddis, 
Uretsky, and Wallace 1995). This suggests that cocaine exerts its effects through multiple 
pathways and the dopamine system is only one of the pathways involved.   
 In conclusion, our model shows that at the highest concentrations of cocaine 
tested, dopamine D2 receptor occupation increased by 30% from a baseline of about 
50%, whereas D1 receptor occupation only increased to about 4% total. Amphetamine 
had a greater effect on dopamine D1 receptor occupation than cocaine, but still only 
increased D1 receptor binding to about 13%. Based on our previous studies, we believe 
that the cocaine and amphetamine induced increase in extracellular dopamine, coupled 
with local signals that increase dopamine release probability or dopamine receptor 
affinity, enhance the strength of the dopamine signal in the striatum, explaining the 
behavioral effects of the drugs.  
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Table 16: Parameter values derived from biochemical data for rodent dorsal striatum. 
Parameter Value 
Dopamine level  79.2 μM a 
Dopamine varicosity density  1x10
+8
/mm
3 b
 
Dopamine transporter level  0.47 μM c 
Dopamine transporter Vmax  4.08 μM/sec 
d
 
Dopamine transporter Km (transfected cells) 2.17 μM 
e
 
Dopamine transporter Km (tissue prep) 0.2 μM 
f
 
Dopamine D1 receptor level 0.01 μM g 
Dopamine D1 receptor Kd 1 μM 
h 
Dopamine D2 receptor level 0.04 μM i 
Dopamine D2 receptor Kd 10 nM 
j 
Cocaine-DAT Kd 0.5 μM 
k
 
Amphetamine-DAT Kd 0.2 μM
l
 
a
 Derived from (Abekawa et al., 2001; Bardullas et al., 2011; Buu, 1989; Cartmell et al., 
2000; Gao and Dluzen, 2001; Miller et al., 1980; Ponzio et al., 1984; Sharp et al., 1986; 
Takahashi et al., 1997; Vezina et al., 1992; Yu et al., 2001; Yuan et al., 2001) 
b
 Derived from (Doucet et al., 1986)  
c
 Derived from (Boja et al., 1995; Bonnet et al., 1986; Chen et al., 1997a; Dubocovich 
and Zahniser, 1985; Erikson et al., 2000; Garreau et al., 1997; Hooks et al., 1994; 
Janowsky et al., 1986; Marshall et al., 1990; Moll et al., 2000; Nakayama et al., 1993; 
Rothman et al., 1994) 
d
 Derived from (Garris and Wightman, 1994; May and Wightman, 1989; Wu et al., 2001) 
e
 Derived from (Carneiro et al., 2002; Chang et al., 2001; Eshleman et al., 1995; Itokawa 
et al., 2000; Kitayama et al., 1992; Lee et al., 1996; Lin and Uhl, 2002; Lin and Uhl, 
2005; Loland et al., 1999; Loland et al., 2002; Melikian and Buckley, 1999; Norregaard 
et al., 1998; Norregaard et al., 2000; Yatin et al., 2002) 
f 
Derived from (Harris and Baldessarinig, 1973; Horn, 1990; Marshall et al., 1990; Near 
et al., 1988; Rothman et al., 2001; Snyder and Coyle, 1969; Wu et al., 2001) 
g
 (Hyttel 1987; Mendes de Freitas et al. 2005) 
h
 (Jakob Kisbye Dreyer and Hounsgaard 2013; Rice and Cragg 2008) 
i 
(Hyttel 1987; Murrin and Zeng 1986; Walters and Carr 1988) 
j
 (Jakob Kisbye Dreyer and Hounsgaard 2013; Rice and Cragg 2008) 
k
 (Han and Gu 2006; Hearn et al. 1991) 
l 
(Harris and Baldessarini 1973; Rothman et al. 2001) 
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Table 17: Parameter values associated with a single varicosity for cocaine model. 
Parameter Value 
Number of dopamine molecules per varicosity 475,000 
Number of vesicles per varicosity 250 
Number of dopamine molecules per vesicle 1,900 
Extracellular volume surrounding a release site (dorsal striatum) 2x10
-15
 liter 
Number of DAT associated with a release site 300 
DAT catalytic rate 9 /sec 
DAT-DA binding on-rate  1.3x10
+8
 M
-1
sec
-1
 
DAT-DA binding off-rate 0.5 sec
-1
 
D1-DA binding on-rate 5x10
5
 M
-1
sec
-1
 
D1-DA binding off-rate 0.4 sec
-1
 
D1 receptor number 220 
D2-DA binding on-rate 8.2x10
7
 M
-1
sec
-1
 
D2-DA binding off-rate 0.4 sec
-1
 
Cocaine-DAT binding on-rate 1.3x10
6 
M
-1
sec
-1
 
Cocaine-DAT binding off-rate 3 sec
-1
 
D2 receptors located on medium spiny neurons 45 
b 
D2 receptors located on dopamine terminals 13 
b 
D2 receptors located on other varicosities 6 
b 
Dopamine diffusion rate 4x10
-6
 cm
2
/sec 
a
 
a
 Derived from (Land et al., 1984; Rice and Cragg, 2008; Schonfuss et al., 2001) 
b 
D2 receptor distribution derived from (Anzalone et al. 2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  113 
Table 18. Parameter values associated with a single varicosity for amphetamine model. 
Parameter Value 
Extracellular volume associated with a release site (dorsal striatum) 2x10
-15
 liter 
Number of DAT associated with a release site 2,500 
DAT catalytic rate 5 /sec 
DAT-DA binding on-rate  1x10
+6
 M
-1
sec
-1 
DAT-DA binding off-rate 0.5 sec
-1
 
D1-DA binding on-rate 5x10
5
 M
-1
sec
-1
 
D1-DA binding off-rate 0.4 sec
-1
 
D1 receptor number 220 
D2-DA binding on-rate 8.2x10
7
 M
-1
sec
-1
 
D2-DA binding off-rate 0.4 sec
-1
 
Amphetamine-DAT binding on-rate 2x10
6 
M
-1
sec
-1
 
Amphetamine-DAT binding off-rate 0.5 sec
-1
 
Non-DAT binding on-rate 1.3x10
3
 M
-1
sec
-1
 
Non-DAT binding off-rate 0.002 sec
-1 
Non-DAT catalytic rate 0.005 /sec 
D2 receptors located on medium spiny neurons 45 
b 
D2 receptors located on dopamine terminals 13 
b 
D2 receptors located on other varicosities 6 
b 
Dopamine diffusion rate 4x10
-6
 cm
2
/sec 
a
 
Amphetamine diffusion rate 4x10
-6
 cm
2
/sec 
a
 
a
 Derived from (Land et al., 1984; Rice and Cragg, 2008; Schonfuss et al., 2001) 
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Table 19: Brain concentrations of cocaine and corresponding i.p. injection dose. 
Cocaine dose (i.p. injection; mg/kg) Cocaine brain concentration
a
 (μM) 
5 1.65 
10 4.41 
15 7.16 
20 9.91 
25 12.67 
a 
Brain concentrations were determined using the best-fit line to the data in Figure 16. 
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Figure 15: Striatal dopamine concentration vs. i.p. cocaine dose. 
Published data of measured increases in striatal extracellular dopamine is shown plotted 
against increasing doses of cocaine (•). Computer simulations were then used to model 
the relationship between cocaine dose and percent increase in striatal extracellular 
dopamine (⧍). Published data are from (Camp, Browman, and Robinson 1994; Church, 
Justice, and Byrd 1987; Coury et al. 1992; Hooks, Duffy, et al. 1994; Inada, Polk, Jin, et 
al. 1992; Inada, Polk, Purser, et al. 1992; Kalivas and Duffy 1993; Maisonneuve and 
Kreek 1994; Nicolaysen, Pan, and Justice Jr. 1988; Rossetti et al. 1991). 
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Figure 16: Concentration of cocaine in rodent brain vs. i.p. cocaine dose. 
Published data from (Benuck, Lajtha, and Reith 1987; Camp, Browman, and Robinson 
1994; Cass and Gerhardt 1994; Maisonneuve and Kreek 1994; Nicolaysen, Pan, and 
Justice Jr. 1988; Reith, Benuck, and Lajtha 1987). 
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Figure 17: Dopamine D1 and D2 receptor occupation in the presence of increasing 
concentrations of cocaine. 
The number of dopamine D2 receptors occupied for all three subsets of D2 receptors 
(solid triangles: D2 autoreceptors on dopamine varicosities; solid circles: D2 receptors on 
other varicosities; open circles: D2 receptors on medium spiny neurons) increases by 
about 30% across all cocaine doses tested.  The number of dopamine D1 receptors (open 
triangles) occupied, however, only increases by about 4% across all cocaine doses tested.  
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In the presence of 2 mg/kg amphetamine, dopamine D1 and D2 receptor occupation 
increases in both the simple and complex models. D1 receptor occupation increases to a 
maximum of 13% above baseline, whereas D2 receptor occupation increases to a 
maximum of 40% above baseline.  
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Figure 18: Dopamine receptor occupation in the presence of 2 mg/kg 
amphetamine. 
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Chapter 6: Significance and Future Perspectives  
 
6.1. Summary and significance of dissertation research 
 
 Dopamine is a highly studied neurotransmitter that is important in movement, 
motivation, reward, learning, attention and memory. It is also implicated in multiple 
disease states such as addiction, Parkinson’s disease, schizophrenia and others. Dopamine 
neurons exist in distinct nuclei. Two of these nuclei, located in the substantia nigra and 
ventral tegmental area, innervate the extended striatum. Dopamine communicates via 
volume transmission throughout the striatal complex. It acts as a modulatory 
neurotransmitter by activating G-protein coupled receptors, which modify a neuron’s 
response through multiple signaling pathways. Because dopamine is modulatory instead 
of excitatory or inhibitory, it is more difficult to study its effects on target neurons 
because there is no easily measured response, such as a direct change in membrane 
potential. While much research has been done on global effects of dopamine, little has 
focused on the individual dopamine release sites. Much of the prominent view of 
dopamine signaling is inferred from studying other neurotransmitter systems, such as 
glutamate or the neuromuscular junction. Both morphological and biophysical data 
suggest that dopamine signals differently from these highly studied neurotransmitters, 
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suggesting that extrapolating what we know about how they operate to the dopamine 
system may not be accurate. Our lab has been utilizing various computer models of 
dopamine signaling to evaluate potential answers to questions on dopamine signaling that 
remain unanswered. One advantage of computer models is the ability to integrate all of 
the players involved in regulating dopamine signaling to create a big picture of dopamine 
signaling at the level of release site and receptors in its vicinity. 
The medium spiny neuron is the only output neuron in the striatum. On average, 
each neuron receives over 10,000 inputs, of which about half are glutamate. These 
neurons are quiescent in their baseline state. In order to generate an action potential to 
code an output message, glutamate inputs need to be active to depolarize dendrites. 
Currents from the depolarization events must then travel from initiation site to the axon 
hillock (Figure 19). The current dissipates at varying rates depending on the diameter of 
the dendrite and the leakiness of the membrane. Currents from various depolarization 
events sum as their paths combine. When the depolarization at the axon hillock reaches 
threshold, an axon potential is initiated. Thus, the pattern of action potentials is a function 
of the number of active glutamate inputs and the leakiness of dendritic membranes. 
Dopamine terminals present in the striatum serve a modulatory role. As dopamine 
receptors are located both at the signal initiation sites and in several locations throughout 
the dendritic tree, where leakiness can be regulated, dopamine has substantial potential 
for modulating the output code of the medium spiny neurons.  
The first step in dopamine’s modulation of medium spiny neuron output is release 
of dopamine from axon varicosities into signal space/compartment. Our results suggest 
that the probability of release of the dopamine contents of a single vesicle induced by 
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each firing event is low. In our opinion, the most parsimonious explanation is that the 
contents of one vesicle are released from a few percent of the varicosities in the dendritic 
tree of any given dopamine neuron. Furthermore, our data suggest that the burst-firing 
pattern of dopamine neurons observed in in vivo experiments has minimal impact by 
itself on the level of extracellular dopamine. Other simulations suggest that under 
baseline conditions about half of dopamine D2 receptors are occupied while negligible 
numbers of D1 receptors are occupied. We interpret these findings as meaning that an 
important component of dopamine signaling is the regulation of probability of vesicular 
release of dopamine. We hypothesize that the low probability of vesicular release 
throughout the vast axonal tree provides a baseline on top of which very localized signals 
are generated. This could be accomplished by increasing action potential conductance in 
the axonal tree or by increasing amount of calcium entering varicosities with each action 
potential. Regarding the latter, nicotinic acetylcholine receptors are expressed on 
dopamine terminals, and activation of these is capable under certain conditions of driving 
dopamine release even in the absence of an action potential (Threlfell et al 2012). Thus, 
localized cholinergic signals could be involved in sculpting dopamine signals. 
Dopamine in extracellular space acts on receptors to influence medium spiny 
neuron output code. This can be accomplished by regulating amount of glutamate release 
or regulating amount of leakiness of medium spiny neuron dendrites. Dopamine has the 
potential to reduce glutamate release via activation of dopamine D2 receptors located on 
glutamate terminals, which would reduce the depolarizing currents in the medium spiny 
neurons. Dopamine also has the ability to modulate the output of the striatum via actions 
within the medium spiny neuron itself. Dopamine D2 receptors are expressed on half of 
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medium spiny neurons. One potential mechanism by which these receptors alter leakiness 
is through activation of inwardly rectifying potassium channels. A second potential 
mechanism that would impact strength of glutamate signals would be inhibition of 
protein kinase A-mediated phosphorylation of AMPA and NMDA receptors. Dopamine 
D1 receptors are expressed on the other half of the output neurons. A potential 
mechanism by which they can influence excitatory inputs is through activation of protein 
kinase A-mediated phosphorylation of AMPA receptors (Snyder et al. 2000). This 
modification amplifies the AMPA current and enhances the glutamate signal, making it 
more likely that the neuron will depolarize beyond its threshold. Therefore, depending on 
which receptors are activated, dopamine has the ability to either enhance the 
depolarization of the medium spiny neurons or diminish it.  
 The effects of D1 receptors on phosphorylation of AMPA receptors has been 
shown in vivo, however, our model suggests that D1 receptors remain unoccupied in most 
dopamine release conditions. One potential explanation as to how these receptors become 
activated is that a local signal, acting at the receptor, has the ability to shift the D1 
receptors into a high affinity state. Richfield et al. determined that about 80% of the D1 
receptor exist in the low affinity state with a Kd around 1 μM (Richfield, Penney, and 
Young 1989). The remaining 20% high affinity D1 receptors had a Kd value between 10-
50 nM (Richfield, Penney, and Young 1989; May 1992). There are two theories to 
describe the affinity state of a G protein-coupled receptor. First, there is a theory that the 
G protein and receptor form a stable interaction regardless of binding state of the 
receptor. This interaction leads to a high affinity for the receptor, and, when bound to an 
agonist, the G protein activates effector proteins without dissociating from the receptor 
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(Hein and Bünemann 2009; Qin et al. 2011). The second theory is the collision-coupling 
model, in which the G protein and receptor are uncoupled and move freely throughout the 
cell membrane. When the receptor binds an agonist, it has a higher affinity for a G-
protein, which then binds, activates and dissociates to activate effector proteins (Hein and 
Bünemann 2009; Skinbjerg et al. 2012). It is not clear what factors influence the 
interaction between the G-protein and receptor, or if receptors are able to switch between 
high and low affinity states easily. However, assuming signals exist that can change the 
affinity state of dopamine D1 receptors, these signals would be able to alter dopamine D1 
receptor activation and have the ability to modulate the striatal output.   
The data in this thesis generated with our model only provide a global perspective 
of the average dopamine release site. We have shown that striatal dopamine has a low 
probability of release and that dopamine D1 receptors are not occupied under multiple 
dopamine release conditions. However, It is possible that distinct pockets exist 
throughout the striatum where other factors, such as receptors located on terminals, 
increase dopamine release probability and greatly increase the extracellular dopamine 
concentration. It is also possible that postsynaptic signals are able to increase the affinity 
of D1 receptors for dopamine, thus enhancing their signaling capability. As a modulatory 
neurotransmitter, dopamine has the ability to alter the output of the striatum through a 
variety of mechanisms, and the dopamine signal does not seem to be solely dependent on 
dopamine neuron firing rate. Based on the data in this thesis, we have shown that the 
traditional view of neurotransmission does not apply to the dopamine system in the 
striatum. Instead, it seems the system is designed to have low, tonic activity that can then 
be emphasized with local signals when necessary.   
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6.2. Future Perspectives 
  
 The results of this dissertation suggest interesting phenomena that need to be 
proven experimentally. This will require development of new technology. Dopamine is a 
modulatory neurotransmitter that activates G-protein coupled receptors, which initiate 
signaling cascades that indirectly affect membrane potential. This makes it difficult to 
directly measure fast changes in dopamine release. Electrochemistry and microdialysis 
techniques are helpful in looking at average dopamine concentrations, but are not small 
enough or precise enough to measure dopamine release from a single terminal. False 
fluorescent neurotransmitters have also been used to look at dopamine release, but the 
temporal sensitivity is not fast enough (Gubernator et al. 2009). More recently, however, 
new techniques have been developed that allow us to study dopamine release in real time.  
 Kress et al. used a dopamine-gated chloride channel from C. elegans to study 
dopamine release from terminals in the rat dorsal striatum. They were able to distinguish 
direct dopamine release, and even see dopamine release driven by nicotinic receptor 
activation (Kress et al. 2014). There are still limitations to this technique, though. The 
receptor has about a 6 μM affinity for dopamine, but also has a low sensitivity to 
norepinephrine and epinephrine. A lentiviral expression system was used to express the 
receptors on medium spiny neurons in striatal slices. Depending on the success of the 
technique, surface expression of the receptor could have had an impact on the results. 
One of the biggest limitations to this study, though, is the fact that it was performed in 
slices and dopamine release was elicited by electrical stimulation. This would not give us 
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data on tonic, baseline dopamine release in vivo. Even with the limitations of this 
experiment, the technology has the potential to be useful in providing further evidence 
that either supports or denies the conclusions of this thesis. If the dopamine-gated 
chloride channel could be transfected and electrophysiological readings taken in vivo, the 
system could potentially be used to determine what physiological dopamine release looks 
like in real time.  
 Another technique that has been recently used to look at dopamine D2 receptor 
occupation in real time utilizes G protein activated inwardly rectifying potassium 
channels (GIRK2) coupled to D2 receptors in the striatum (Marcott, Mamaligas, and Ford 
2014). This group virally overexpressed the GIRK2 channels in mouse striatum and the 
outward currents were used as a sensor of dopamine D2 receptor activation. Again, 
measurements were taken from striatal slices, and dopamine release was either 
electrically or optogenetically evoked. If the electrophysiological readings could be taken 
in vivo, the system could potentially be used to determine what dopamine D2 receptor 
occupation looks like in real time, under multiple circumstances like those tested using 
our model.  
 While no current technique exists to look at dopamine D1 receptor occupation in 
real-time, the new techniques discussed above offer a framework for potential ways to 
monitor D1 receptor occupation, if a reporter with high specificity can be found. These 
techniques open up new avenues for investigating how modulatory neurotransmitter 
systems work in real-time and can supplement and improve our models of the dopamine 
terminal.   
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Figure 19: Dopamine modulation of striatal output. 
The medium spiny neuron is the only output neuron in the striatum, and the pattern of 
action potentials initiated at the axon hillock provide the code for striatally regulated 
functions. In order to generate an action potential at the axon hillock, various glutamate 
inputs initiate small currents that must travel to the axon hillock. The amount of signal 
arriving can be modulated by varying leakiness of dendritic membranes. When the 
current reaching the axon hillock is strong enough to depolarize the membrane past the 
threshold, the neuron will fire. Dopamine signals in the striatum act both to modulate the 
magnitude of the glutamate input and the leakiness of the membrane. Ways in which this 
can be accomplished include the following. First, dopamine D2 receptors exist on 
glutamate inputs, which, when activated, reduce glutamate release. Second, postsynaptic 
signals may increase dopamine D1 receptor affinity for ligand, thus increasing D1 
receptor signaling. Activation of dopamine D1 receptors expressed on the dendrites of the 
medium spiny neuron has been shown to increase phosphorylation of AMPA receptors 
and potentiate the current (G. L. Snyder et al. 2000). Signals acting at dopamine 
terminals, such as activation of nicotinic acetylcholine receptors or dopamine D2 
receptors, would alter dopamine release probability, which would affect dopamine 
signaling. An additional potential effect of activation of D2 receptors is opening of 
potassium channels in dendrites with the effect of increasing membrane leakiness.   
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